Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C112765 |
17-(allylamino)-17-demethoxygeldanamycin |
[17-(allylamino)-17-demethoxygeldanamycin co-treated with TNFSF10 protein] results in decreased expression of XIAP protein | affects cotreatment|decreases expression | 15993848
|
C112765 |
17-(allylamino)-17-demethoxygeldanamycin |
[17-(allylamino)-17-demethoxygeldanamycin co-treated with TNFSF10 protein] results in increased activity of CASP3 protein | affects cotreatment|increases activity | 15993848
|
C063002 |
2,3-dimethoxy-1,4-naphthoquinone |
2,3-dimethoxy-1,4-naphthoquinone results in decreased expression of TNFSF10 mRNA | decreases expression | 17547211
|
C009505 |
4,4'-diaminodiphenylmethane |
4,4'-diaminodiphenylmethane results in increased expression of TNFSF10 mRNA | increases expression | 18648102
|
C119130 |
4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide |
TNFSF10 protein affects the susceptibility to 4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide | affects response to substance | 12203115
|
C119130 |
4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide |
TNFSF10 protein promotes the reaction [4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide results in increased cleavage of and results in increased activity of CASP3 protein] | increases activity|increases cleavage|increases reaction | 12203115
|
C119130 |
4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide |
TNFSF10 protein promotes the reaction [4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide results in increased cleavage of and results in increased activity of CASP8 protein] | increases activity|increases cleavage|increases reaction | 12203115
|
C119130 |
4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide |
TNFSF10 protein promotes the reaction [4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide results in increased cleavage of and results in increased activity of CASP9 protein] | increases activity|increases cleavage|increases reaction | 12203115
|
C405354 |
4,5,6,7-tetrabromobenzotriazole |
[4,5,6,7-tetrabromobenzotriazole co-treated with TNFSF10 protein] results in decreased expression of BCL2L1 protein | affects cotreatment|decreases expression | 16489027
|
C405354 |
4,5,6,7-tetrabromobenzotriazole |
[4,5,6,7-tetrabromobenzotriazole co-treated with TNFSF10 protein] results in decreased expression of BCL2 protein | affects cotreatment|decreases expression | 16489027
|
C405354 |
4,5,6,7-tetrabromobenzotriazole |
[4,5,6,7-tetrabromobenzotriazole co-treated with TNFSF10 protein] results in increased activity of CASP8 protein | affects cotreatment|increases activity | 16489027
|
C405354 |
4,5,6,7-tetrabromobenzotriazole |
[4,5,6,7-tetrabromobenzotriazole co-treated with TNFSF10 protein] results in increased cleavage of and results in increased activity of CASP3 protein | affects cotreatment|increases activity|increases cleavage | 16489027
|
C405354 |
4,5,6,7-tetrabromobenzotriazole |
[4,5,6,7-tetrabromobenzotriazole co-treated with TNFSF10 protein] results in increased cleavage of and results in increased activity of CASP9 protein | affects cotreatment|increases activity|increases cleavage | 16489027
|
C405354 |
4,5,6,7-tetrabromobenzotriazole |
[4,5,6,7-tetrabromobenzotriazole co-treated with TNFSF10 protein] results in increased expression of BAX protein | affects cotreatment|increases expression | 16489027
|
C110962 |
5,6-dichlorobenzimidazole |
5,6-dichlorobenzimidazole promotes the reaction [TNFSF10 protein affects the localization of AIFM1 protein] | affects localization|increases reaction | 15688023
|
C110962 |
5,6-dichlorobenzimidazole |
5,6-dichlorobenzimidazole promotes the reaction [TNFSF10 protein affects the localization of CYCS protein] | affects localization|increases reaction | 15688023
|
C110962 |
5,6-dichlorobenzimidazole |
5,6-dichlorobenzimidazole promotes the reaction [TNFSF10 protein affects the localization of DIABLO protein] | affects localization|increases reaction | 15688023
|
C110962 |
5,6-dichlorobenzimidazole |
5,6-dichlorobenzimidazole promotes the reaction [TNFSF10 protein affects the localization of HTRA2 protein] | affects localization|increases reaction | 15688023
|
C110962 |
5,6-dichlorobenzimidazole |
5,6-dichlorobenzimidazole promotes the reaction [TNFSF10 protein results in increased cleavage of BID protein] | increases cleavage|increases reaction | 15688023
|
C110962 |
5,6-dichlorobenzimidazole |
5,6-dichlorobenzimidazole promotes the reaction [TNFSF10 protein results in increased cleavage of CASP3 protein] | increases cleavage|increases reaction | 15688023
|
C110962 |
5,6-dichlorobenzimidazole |
5,6-dichlorobenzimidazole promotes the reaction [TNFSF10 protein results in increased cleavage of CASP8 protein] | increases cleavage|increases reaction | 15688023
|
C110962 |
5,6-dichlorobenzimidazole |
5,6-dichlorobenzimidazole promotes the reaction [TNFSF10 protein results in increased cleavage of CASP9 protein] | increases cleavage|increases reaction | 15688023
|
C110962 |
5,6-dichlorobenzimidazole |
5,6-dichlorobenzimidazole promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein] | increases cleavage|increases reaction | 15688023
|
D000111 |
Acetylcysteine |
Acetylcysteine results in decreased expression of TNFSF10 mRNA | decreases expression | 16084531
|
C103303 |
alitretinoin |
alitretinoin results in increased expression of TNFSF10 mRNA | increases expression | 16449964
|
C103303 |
alitretinoin |
alitretinoin results in increased expression of TNFSF10 protein | increases expression | 16449964
|
D000584 |
Amiloride |
Amiloride promotes the reaction [TNFSF10 protein affects the localization of CYCS protein] | affects localization|increases reaction | 15607733
|
D000584 |
Amiloride |
Amiloride promotes the reaction [TNFSF10 protein results in increased activity of CASP3 protein] | increases activity|increases reaction | 15607733
|
D000584 |
Amiloride |
Amiloride promotes the reaction [TNFSF10 protein results in increased activity of CASP8 protein] | increases activity|increases reaction | 15607733
|
D000584 |
Amiloride |
Amiloride promotes the reaction [TNFSF10 protein results in increased cleavage of and results in increased activity of CASP3 protein] | increases activity|increases cleavage|increases reaction | 16059913
|
D000584 |
Amiloride |
Amiloride promotes the reaction [TNFSF10 protein results in increased cleavage of and results in increased activity of CASP8 protein] | increases activity|increases cleavage|increases reaction | 16059913
|
D000584 |
Amiloride |
Amiloride promotes the reaction [TNFSF10 protein results in increased cleavage of and results in increased activity of CASP9 protein] | increases activity|increases cleavage|increases reaction | 16059913
|
D000584 |
Amiloride |
Amiloride promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein] | increases cleavage|increases reaction | 15607733 16059913
|
D000584 |
Amiloride |
Okadaic Acid inhibits the reaction [Amiloride promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein]] | decreases reaction|increases cleavage|increases reaction | 16059913
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of TNFSF10 mRNA | affects expression | 16483693
|
D000965 |
Antimony |
Antimony results in decreased expression of TNFSF10 mRNA | decreases expression | 17547211
|
D000966 |
Antimony Potassium Tartrate |
Antimony Potassium Tartrate results in decreased expression of TNFSF10 mRNA | decreases expression | 17547211
|
C004984 |
apocarotenal |
apocarotenal results in increased expression of TNFSF10 mRNA | increases expression | 17034753
|
D001151 |
Arsenic |
[Arsenic co-treated with Fluorides] results in decreased expression of TNFSF10 mRNA | affects cotreatment|decreases expression | 19962721
|
D001151 |
Arsenic |
Arsenic results in decreased expression of TNFSF10 mRNA | decreases expression | 19962721
|
D001151 |
Arsenic |
Arsenic results in increased expression of TNFSF10 mRNA | increases expression | 11134558
|
C006632 |
arsenic trioxide |
[arsenic trioxide co-treated with bortezomib] results in increased expression of TNFSF10 | affects cotreatment|increases expression | 20471514
|
C006632 |
arsenic trioxide |
arsenic trioxide results in decreased expression of TNFSF10 mRNA | decreases expression | 20458559 17530438
|
D001205 |
Ascorbic Acid |
[Quercetin co-treated with Ascorbic Acid] results in decreased expression of TNFSF10 mRNA | affects cotreatment|decreases expression | 17639512
|
D019207 |
beta Carotene |
beta Carotene results in increased expression of TNFSF10 mRNA | increases expression | 17034753
|
C400082 |
bortezomib |
[arsenic trioxide co-treated with bortezomib] results in increased expression of TNFSF10 | affects cotreatment|increases expression | 20471514
|
D020122 |
tert-Butylhydroperoxide |
tert-Butylhydroperoxide results in decreased expression of TNFSF10 mRNA | decreases expression | 15336504
|
D002104 |
Cadmium |
Cadmium results in decreased expression of TNFSF10 mRNA | decreases expression | 17547211
|
D019256 |
Cadmium Chloride |
Cadmium Chloride results in decreased expression of TNFSF10 mRNA | decreases expression | 17547211
|
D019256 |
Cadmium Chloride |
[sodium arsenite co-treated with Cadmium Chloride co-treated with chromium oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of TNFSF10 mRNA | affects cotreatment|decreases expression | 12634122
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride results in increased expression of TNFSF10 mRNA | increases expression | 17038628
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride results in increased expression of TNFSF10 protein | increases expression | 17038628
|
D002251 |
Carbon Tetrachloride |
copolymer 1 promotes the reaction [Carbon Tetrachloride results in increased expression of TNFSF10 mRNA] | increases expression|increases reaction | 17038628
|
D002251 |
Carbon Tetrachloride |
copolymer 1 promotes the reaction [Carbon Tetrachloride results in increased expression of TNFSF10 protein] | increases expression|increases reaction | 17038628
|
D020111 |
Chlorodiphenyl (54% Chlorine) |
Chlorodiphenyl (54% Chlorine) results in decreased expression of TNFSF10 mRNA | decreases expression | 17851650 16934159
|
D002784 |
Cholesterol |
Cholesterol analog results in increased expression of TNFSF10 mRNA | increases expression | 19477266
|
D002784 |
Cholesterol |
Cholesterol analog results in increased expression of TNFSF10 protein | increases expression | 19477266
|
D002857 |
Chromium |
Chromium results in decreased expression of TNFSF10 mRNA | decreases expression | 17547211
|
C023600 |
chromium oxide |
[sodium arsenite co-treated with Cadmium Chloride co-treated with chromium oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of TNFSF10 mRNA | affects cotreatment|decreases expression | 12634122
|
C017133 |
chromous chloride |
[sodium arsenite co-treated with Cadmium Chloride co-treated with chromium oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of TNFSF10 mRNA | affects cotreatment|decreases expression | 12634122
|
C089995 |
copolymer 1 |
copolymer 1 promotes the reaction [Carbon Tetrachloride results in increased expression of TNFSF10 mRNA] | increases expression|increases reaction | 17038628
|
C089995 |
copolymer 1 |
copolymer 1 promotes the reaction [Carbon Tetrachloride results in increased expression of TNFSF10 protein] | increases expression|increases reaction | 17038628
|
D003474 |
Curcumin |
Curcumin results in decreased expression of TNFSF10 mRNA | decreases expression | 16101141 15713895
|
D003474 |
Curcumin |
TNFSF10 protein promotes the reaction [Curcumin results in decreased activity of RELA protein] | decreases activity|increases reaction | 18226269
|
D003474 |
Curcumin |
TNFSF10 protein promotes the reaction [Curcumin results in decreased expression of BCL2L1 protein] | decreases expression|increases reaction | 18226269
|
D003474 |
Curcumin |
TNFSF10 protein promotes the reaction [Curcumin results in decreased expression of BCL2 protein] | decreases expression|increases reaction | 18226269
|
D003474 |
Curcumin |
TNFSF10 protein promotes the reaction [Curcumin results in decreased expression of CCND1 protein] | decreases expression|increases reaction | 18226269
|
D003474 |
Curcumin |
TNFSF10 protein promotes the reaction [Curcumin results in decreased expression of IL8 protein] | decreases expression|increases reaction | 18226269
|
D003474 |
Curcumin |
TNFSF10 protein promotes the reaction [Curcumin results in decreased expression of MMP2 protein] | decreases expression|increases reaction | 18226269
|
D003474 |
Curcumin |
TNFSF10 protein promotes the reaction [Curcumin results in decreased expression of MMP9 protein] | decreases expression|increases reaction | 18226269
|
D003474 |
Curcumin |
TNFSF10 protein promotes the reaction [Curcumin results in decreased expression of PLAU protein] | decreases expression|increases reaction | 18226269
|
D003474 |
Curcumin |
TNFSF10 protein promotes the reaction [Curcumin results in decreased expression of PTGS2 protein] | decreases expression|increases reaction | 18226269
|
D003474 |
Curcumin |
TNFSF10 protein promotes the reaction [Curcumin results in decreased expression of VEGFA protein] | decreases expression|increases reaction | 18226269
|
D003474 |
Curcumin |
TNFSF10 protein promotes the reaction [Curcumin results in increased expression of BAK1 protein] | increases expression|increases reaction | 18226269
|
D003474 |
Curcumin |
TNFSF10 protein promotes the reaction [Curcumin results in increased expression of BAX protein] | increases expression|increases reaction | 18226269
|
D003474 |
Curcumin |
TNFSF10 protein promotes the reaction [Curcumin results in increased expression of CDKN1A protein] | increases expression|increases reaction | 18226269
|
D003474 |
Curcumin |
TNFSF10 protein promotes the reaction [Curcumin results in increased expression of CDKN1B protein] | increases expression|increases reaction | 18226269
|
D003474 |
Curcumin |
TNFSF10 protein promotes the reaction [Curcumin results in increased expression of TNFRSF10A protein] | increases expression|increases reaction | 18226269
|
D003474 |
Curcumin |
TNFSF10 protein promotes the reaction [Curcumin results in increased expression of TNFRSF10B protein] | increases expression|increases reaction | 18226269
|
D003513 |
Cycloheximide |
Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of TNFSF10 mRNA] | decreases expression|decreases reaction | 11007951
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of TNFSF10 mRNA | decreases expression | 20106945
|
D003561 |
Cytarabine |
Cytarabine results in increased expression of TNFSF10 mRNA | increases expression | 19194470
|
D003606 |
Dacarbazine |
TNFSF10 protein promotes the reaction [Dacarbazine results in increased cleavage of and results in increased activity of CASP3 protein] | increases activity|increases cleavage|increases reaction | 17410615
|
D003606 |
Dacarbazine |
TNFSF10 protein promotes the reaction [Dacarbazine results in increased cleavage of and results in increased activity of CASP8 protein] | increases activity|increases cleavage|increases reaction | 17410615
|
C014347 |
decitabine |
[decitabine co-treated with TNFSF10 protein] results in increased activity of CASP8 protein | affects cotreatment|increases activity | 18636160
|
C014347 |
decitabine |
[decitabine co-treated with TNFSF10 protein] results in increased activity of CASP9 protein | affects cotreatment|increases activity | 18636160
|
C014347 |
decitabine |
[decitabine co-treated with TNFSF10 protein] results in increased cleavage of PARP1 protein | affects cotreatment|increases cleavage | 18636160
|
D003907 |
Dexamethasone |
Dexamethasone inhibits the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein] | decreases reaction|increases cleavage | 16144937
|
D002945 |
Cisplatin |
Cisplatin results in increased activity of TNFSF10 protein | increases activity | 16638878
|
D002945 |
Cisplatin |
TNFSF10 protein affects the susceptibility to Cisplatin | affects response to substance | 16638878 16217747
|
C121718 |
dicyclanil |
[dicyclanil co-treated with Diethylnitrosamine] results in decreased expression of TNFSF10 mRNA | affects cotreatment|decreases expression | 17162532
|
D004041 |
Dietary Fats |
Dietary Fats results in decreased expression of TNFSF10 mRNA | decreases expression | 18042831
|
D004052 |
Diethylnitrosamine |
[dicyclanil co-treated with Diethylnitrosamine] results in decreased expression of TNFSF10 mRNA | affects cotreatment|decreases expression | 17162532
|
D004052 |
Diethylnitrosamine |
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of TNFSF10 mRNA | affects cotreatment|decreases expression | 18544905
|
D004054 |
Diethylstilbestrol |
Diethylstilbestrol results in increased expression of TNFSF10 mRNA | increases expression | 15545218
|
D004126 |
Dimethylformamide |
Dimethylformamide results in increased expression of TNFSF10 mRNA | increases expression | 18063697
|
D004126 |
Dimethylformamide |
Dimethylformamide results in increased expression of TNFSF10 protein | increases expression | 18063697
|
D004128 |
Dimethylnitrosamine |
Dimethylnitrosamine results in decreased expression of TNFSF10 protein | decreases expression | 17849272
|
D004317 |
Doxorubicin |
Doxorubicin results in increased expression of TNFSF10 mRNA | increases expression | 19106633
|
D004317 |
Doxorubicin |
Doxorubicin results in increased expression of TNFSF10 protein | increases expression | 19106633
|
D004317 |
Doxorubicin |
TNFSF10 protein affects the susceptibility to Doxorubicin | affects response to substance | 19106633
|
D004317 |
Doxorubicin |
TNFSF10 protein promotes the reaction [Doxorubicin results in increased activity of CASP3 protein] | increases activity|increases reaction | 19106633
|
D004317 |
Doxorubicin |
TNFSF10 protein promotes the reaction [Doxorubicin results in increased activity of CASP7 protein] | increases activity|increases reaction | 19106633
|
D004317 |
Doxorubicin |
TP53 protein promotes the reaction [Doxorubicin results in increased expression of TNFSF10 mRNA] | increases expression|increases reaction | 19106633
|
D004317 |
Doxorubicin |
TP53 protein promotes the reaction [Doxorubicin results in increased expression of TNFSF10 protein] | increases expression|increases reaction | 19106633
|
D004317 |
Doxorubicin |
[Doxorubicin results in increased activity of SMPD1 protein] promotes the reaction [TNFSF10 protein binds to TNFSF10 protein] | affects binding|increases activity|increases reaction | 17520194
|
D004317 |
Doxorubicin |
Doxorubicin results in increased secretion of TNFSF10 protein | increases secretion | 15703961
|
C045651 |
epigallocatechin gallate |
epigallocatechin gallate results in decreased expression of TNFSF10 mRNA | decreases expression | 16084531
|
D004958 |
Estradiol |
[Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of TNFSF10 mRNA | affects cotreatment|increases expression | 19619570
|
D004958 |
Estradiol |
Estradiol results in decreased expression of TNFSF10 mRNA | decreases expression | 20106945
|
D004958 |
Estradiol |
Estradiol results in increased expression of TNFSF10 mRNA | increases expression | 19619570
|
D000431 |
Ethanol |
Ethanol results in decreased expression of TNFSF10 protein | decreases expression | 18166357
|
D005419 |
Flavonoids |
Flavonoids results in decreased expression of TNFSF10 mRNA | decreases expression | 18035473
|
D005459 |
Fluorides |
[Arsenic co-treated with Fluorides] results in decreased expression of TNFSF10 mRNA | affects cotreatment|decreases expression | 19962721
|
D005459 |
Fluorides |
Fluorides results in decreased expression of TNFSF10 mRNA | decreases expression | 19962721
|
D005472 |
Fluorouracil |
CFLAR protein alternative form inhibits the reaction [Fluorouracil results in increased activity of TNFSF10 protein] | decreases reaction|increases activity | 16373718
|
D005472 |
Fluorouracil |
[Fluorouracil co-treated with TNFSF10 protein] results in increased cleavage of and results in increased activity of CASP3 protein | affects cotreatment|increases activity|increases cleavage | 15120327
|
D005472 |
Fluorouracil |
Fluorouracil results in increased activity of TNFSF10 protein | increases activity | 16373718
|
D005472 |
Fluorouracil |
Fluorouracil results in increased expression of TNFSF10 mRNA | increases expression | 19106633
|
D005472 |
Fluorouracil |
Fluorouracil results in increased expression of TNFSF10 protein | increases expression | 19106633
|
D005472 |
Fluorouracil |
TP53 protein promotes the reaction [Fluorouracil results in increased expression of TNFSF10 mRNA] | increases expression|increases reaction | 19106633
|
D005472 |
Fluorouracil |
TP53 protein promotes the reaction [Fluorouracil results in increased expression of TNFSF10 protein] | increases expression|increases reaction | 19106633
|
D005472 |
Fluorouracil |
Fluorouracil results in increased expression of TNFSF10 protein | increases expression | 19106633
|
D005665 |
Furosemide |
Furosemide affects the expression of TNFSF10 mRNA | affects expression | 17497460
|
D019833 |
Genistein |
Genistein results in decreased expression of TNFSF10 mRNA | decreases expression | 16169203
|
D017313 |
Fenretinide |
[Fenretinide co-treated with TNFSF10 protein] results in increased activity of CASP10 protein | affects cotreatment|increases activity | 17273769
|
D017313 |
Fenretinide |
[Fenretinide co-treated with TNFSF10 protein] results in increased activity of CASP3 protein | affects cotreatment|increases activity | 17273769
|
D017313 |
Fenretinide |
[Fenretinide co-treated with TNFSF10 protein] results in increased activity of CASP8 protein | affects cotreatment|increases activity | 17273769
|
D017313 |
Fenretinide |
[Fenretinide co-treated with TNFSF10 protein] results in increased activity of CASP9 protein | affects cotreatment|increases activity | 17273769
|
D017313 |
Fenretinide |
[Fenretinide co-treated with TNFSF10 protein] results in increased cleavage of BID protein | affects cotreatment|increases cleavage | 17273769
|
D017313 |
Fenretinide |
[Fenretinide co-treated with TNFSF10 protein] results in increased cleavage of PARP1 protein | affects cotreatment|increases cleavage | 17273769
|
C051890 |
irinotecan |
CFLAR protein alternative form inhibits the reaction [irinotecan results in increased activity of TNFSF10 protein] | decreases reaction|increases activity | 16373718
|
C051890 |
irinotecan |
irinotecan results in increased activity of TNFSF10 protein | increases activity | 16373718
|
D007501 |
Iron |
Iron deficiency results in increased expression of TNFSF10 mRNA | increases expression | 20368581
|
D007530 |
Isoflurane |
Isoflurane results in decreased expression of TNFSF10 mRNA | decreases expression | 16978161
|
C011890 |
kojic acid |
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of TNFSF10 mRNA | affects cotreatment|decreases expression | 18544905
|
C008261 |
lead acetate |
[sodium arsenite co-treated with Cadmium Chloride co-treated with chromium oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of TNFSF10 mRNA | affects cotreatment|decreases expression | 12634122
|
D047311 |
Luteolin |
Luteolin promotes the reaction [TNFSF10 protein results in increased activity of CASP3 protein] | increases activity|increases reaction | 16140950
|
D047311 |
Luteolin |
Luteolin promotes the reaction [TNFSF10 protein results in increased activity of CASP8 protein] | increases activity|increases reaction | 16140950
|
D047311 |
Luteolin |
Luteolin promotes the reaction [TNFSF10 protein results in increased ubiquitination of and results in increased degradation of and results in decreased expression of XIAP protein] | decreases expression|increases degradation|increases reaction|increases ubiquitination | 16140950
|
D008628 |
Mercury |
Mercury results in decreased expression of TNFSF10 mRNA | decreases expression | 17547211
|
D016685 |
Mitomycin |
[Mitomycin co-treated with TNFSF10 protein] results in increased cleavage of and results in increased activity of CASP3 protein | affects cotreatment|increases activity|increases cleavage | 15120327
|
D009151 |
Mustard Gas |
Mustard Gas results in increased expression of TNFSF10 mRNA | increases expression | 15674843
|
C058815 |
N-(2-aminoethyl)-5-chloroisoquinoline-8-sulfonamide |
N-(2-aminoethyl)-5-chloroisoquinoline-8-sulfonamide promotes the reaction [TNFSF10 protein results in increased expression of BIRC2 protein] | increases expression|increases reaction | 15520213
|
C058815 |
N-(2-aminoethyl)-5-chloroisoquinoline-8-sulfonamide |
N-(2-aminoethyl)-5-chloroisoquinoline-8-sulfonamide promotes the reaction [TNFSF10 protein results in increased expression of XIAP protein] | increases expression|increases reaction | 15520213
|
C022838 |
nickel chloride |
nickel chloride results in decreased expression of TNFSF10 mRNA | decreases expression | 17547211
|
D009637 |
Nordihydroguaiaretic Acid |
[Nordihydroguaiaretic Acid co-treated with TNFSF10 protein] results in increased cleavage of and results in increased activity of BID protein | affects cotreatment|increases activity|increases cleavage | 17645780
|
D009637 |
Nordihydroguaiaretic Acid |
[Nordihydroguaiaretic Acid co-treated with TNFSF10 protein] results in increased cleavage of and results in increased activity of CASP10 protein | affects cotreatment|increases activity|increases cleavage | 17645780
|
D009637 |
Nordihydroguaiaretic Acid |
[Nordihydroguaiaretic Acid co-treated with TNFSF10 protein] results in increased cleavage of and results in increased activity of CASP3 protein | affects cotreatment|increases activity|increases cleavage | 17645780
|
D009637 |
Nordihydroguaiaretic Acid |
[Nordihydroguaiaretic Acid co-treated with TNFSF10 protein] results in increased cleavage of and results in increased activity of CASP8 protein | affects cotreatment|increases activity|increases cleavage | 17645780
|
D019319 |
Okadaic Acid |
Okadaic Acid inhibits the reaction [Amiloride promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein]] | decreases reaction|increases cleavage|increases reaction | 16059913
|
C055122 |
orlistat |
orlistat results in increased susceptibility to TNFSF10 protein | increases response to substance | 21406729 18796435
|
C030110 |
oxaliplatin |
CFLAR protein alternative form inhibits the reaction [oxaliplatin results in increased activity of TNFSF10 protein] | decreases reaction|increases activity | 16373718
|
C030110 |
oxaliplatin |
oxaliplatin results in increased activity of TNFSF10 protein | increases activity | 16373718
|
D010126 |
Ozone |
Ozone results in decreased expression of TNFSF10 mRNA | decreases expression | 17095637
|
C041786 |
palm oil |
palm oil results in decreased expression of TNFSF10 mRNA | decreases expression | 18042831
|
C482884 |
panduratin A |
panduratin A results in increased expression of TNFSF10 protein | increases expression | 16497706
|
D010634 |
Phenobarbital |
Phenobarbital results in increased expression of TNFSF10 mRNA | increases expression | 19270015
|
D011070 |
Poly I-C |
Poly I-C results in increased expression of TNFSF10 mRNA | increases expression | 16472598
|
D011070 |
Poly I-C |
Poly I-C results in increased expression of TNFSF10 protein | increases expression | 16472598
|
C025299 |
polyphenols |
polyphenols results in decreased expression of TNFSF10 mRNA | decreases expression | 16293270
|
D011192 |
Potassium Dichromate |
Potassium Dichromate results in decreased expression of TNFSF10 mRNA | decreases expression | 17547211
|
D011374 |
Progesterone |
Progesterone results in decreased expression of TNFSF10 mRNA | decreases expression | 18070364
|
D011794 |
Quercetin |
[Quercetin co-treated with Ascorbic Acid] results in decreased expression of TNFSF10 mRNA | affects cotreatment|decreases expression | 17639512
|
D011794 |
Quercetin |
[Quercetin co-treated with TNFSF10 protein] results in increased cleavage of CASP3 protein | affects cotreatment|increases cleavage | 18980244
|
D011794 |
Quercetin |
[Quercetin co-treated with TNFSF10 protein] results in increased expression of ANXA5 protein | affects cotreatment|increases expression | 18377872
|
D011794 |
Quercetin |
Quercetin promotes the reaction [TNFSF10 protein affects the localization of BAX protein] | affects localization|increases reaction | 17876056
|
D011794 |
Quercetin |
Quercetin promotes the reaction [TNFSF10 protein affects the localization of CASP8 protein] | affects localization|increases reaction | 17876056
|
D011794 |
Quercetin |
Quercetin promotes the reaction [TNFSF10 protein affects the localization of FADD protein] | affects localization|increases reaction | 17876056
|
D011794 |
Quercetin |
Quercetin promotes the reaction [TNFSF10 protein affects the localization of TNFRSF10A protein] | affects localization|increases reaction | 17876056
|
D011794 |
Quercetin |
Quercetin promotes the reaction [TNFSF10 protein affects the localization of TNFRSF10B protein] | affects localization|increases reaction | 17876056
|
D011794 |
Quercetin |
Quercetin promotes the reaction [TNFSF10 protein results in increased activity of CASP3 protein] | increases activity|increases reaction | 18377872
|
D011794 |
Quercetin |
Quercetin promotes the reaction [TNFSF10 protein results in increased activity of CASP8 protein] | increases activity|increases reaction | 18377872
|
D011794 |
Quercetin |
Quercetin promotes the reaction [TNFSF10 protein results in increased activity of CASP9 protein] | increases activity|increases reaction | 18377872
|
D011794 |
Quercetin |
Quercetin promotes the reaction [TNFSF10 protein results in increased cleavage of BID protein] | increases cleavage|increases reaction | 17876056
|
D011794 |
Quercetin |
Quercetin promotes the reaction [TNFSF10 protein results in increased cleavage of CASP3 protein] | increases cleavage|increases reaction | 17876056
|
D011794 |
Quercetin |
Quercetin promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein] | increases cleavage|increases reaction | 17876056 18377872
|
C059514 |
resveratrol |
[resveratrol co-treated with TNFSF10 protein] results in increased activity of CASP2 protein | affects cotreatment|increases activity | 15763656
|
C059514 |
resveratrol |
[resveratrol co-treated with TNFSF10 protein] results in increased activity of CASP3 protein | affects cotreatment|increases activity | 15763656
|
C059514 |
resveratrol |
[resveratrol co-treated with TNFSF10 protein] results in increased activity of CASP6 protein | affects cotreatment|increases activity | 15763656
|
C059514 |
resveratrol |
[resveratrol co-treated with TNFSF10 protein] results in increased activity of CASP8 protein | affects cotreatment|increases activity | 15763656
|
C059514 |
resveratrol |
[resveratrol co-treated with TNFSF10 protein] results in increased activity of CASP9 protein | affects cotreatment|increases activity | 15763656
|
C059514 |
resveratrol |
resveratrol promotes the reaction [TNFSF10 protein results in increased cleavage of CASP3 protein] | increases cleavage|increases reaction | 17823925
|
C059514 |
resveratrol |
resveratrol promotes the reaction [TNFSF10 protein results in increased cleavage of CASP7 protein] | increases cleavage|increases reaction | 17823925
|
C059514 |
resveratrol |
resveratrol promotes the reaction [TNFSF10 protein results in increased cleavage of CASP8 protein] | increases cleavage|increases reaction | 17823925
|
C059514 |
resveratrol |
resveratrol promotes the reaction [TNFSF10 protein results in increased cleavage of CASP9 protein] | increases cleavage|increases reaction | 17823925
|
C059514 |
resveratrol |
resveratrol promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein] | increases cleavage|increases reaction | 17823925
|
D012643 |
Selenium |
Selenium results in decreased expression of TNFSF10 mRNA | decreases expression | 19244175
|
C002979 |
selenomethylselenocysteine |
[selenomethylselenocysteine results in decreased expression of BCL2 mRNA] which results in increased activity of TNFSF10 protein | decreases expression|increases activity | 19360359
|
C017947 |
sodium arsenite |
BLVRA protein inhibits the reaction [sodium arsenite results in increased expression of TNFSF10 protein] | decreases reaction|increases expression | 15741166
|
C017947 |
sodium arsenite |
[sodium arsenite co-treated with Cadmium Chloride co-treated with chromium oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of TNFSF10 mRNA | affects cotreatment|decreases expression | 12634122
|
C017947 |
sodium arsenite |
sodium arsenite results in decreased expression of TNFSF10 mRNA | decreases expression | 12727804
|
C017947 |
sodium arsenite |
sodium arsenite results in increased expression of TNFSF10 protein | increases expression | 15741166
|
C017947 |
sodium arsenite |
sodium arsenite results in decreased expression of TNFSF10 mRNA | decreases expression | 19822182
|
D018038 |
Sodium Selenite |
Sodium Selenite results in decreased expression of TNFSF10 mRNA | decreases expression | 16705456
|
C025462 |
sulindac sulfide |
BAX protein affects the reaction [TNFSF10 protein promotes the reaction [sulindac sulfide results in increased cleavage of and results in increased activity of CASP3 protein]] | affects reaction|increases activity|increases cleavage|increases reaction | 12203115
|
C025462 |
sulindac sulfide |
BAX protein affects the reaction [TNFSF10 protein promotes the reaction [sulindac sulfide results in increased cleavage of and results in increased activity of CASP8 protein]] | affects reaction|increases activity|increases cleavage|increases reaction | 12203115
|
C025462 |
sulindac sulfide |
BAX protein affects the reaction [TNFSF10 protein promotes the reaction [sulindac sulfide results in increased cleavage of and results in increased activity of CASP9 protein]] | affects reaction|increases activity|increases cleavage|increases reaction | 12203115
|
C025462 |
sulindac sulfide |
TNFSF10 protein promotes the reaction [sulindac sulfide results in increased cleavage of and results in increased activity of CASP3 protein] | increases activity|increases cleavage|increases reaction | 12203115
|
C025462 |
sulindac sulfide |
TNFSF10 protein promotes the reaction [sulindac sulfide results in increased cleavage of and results in increased activity of CASP8 protein] | increases activity|increases cleavage|increases reaction | 12203115
|
C025462 |
sulindac sulfide |
TNFSF10 protein promotes the reaction [sulindac sulfide results in increased cleavage of and results in increased activity of CASP9 protein] | increases activity|increases cleavage|increases reaction | 12203115
|
C004648 |
testosterone enanthate |
testosterone enanthate affects the expression of TNFSF10 mRNA | affects expression | 17440010
|
D013749 |
Tetrachlorodibenzodioxin |
Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of TNFSF10 mRNA] | decreases expression|decreases reaction | 11007951
|
D013749 |
Tetrachlorodibenzodioxin |
[Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of TNFSF10 mRNA | affects cotreatment|increases expression | 19619570
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of TNFSF10 mRNA | decreases expression | 11007951 11489354
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of TNFSF10 mRNA | increases expression | 19619570
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of TNFSF10 mRNA | increases expression | 14718643 12167310 15310856
|
D013792 |
Thalidomide |
Thalidomide results in decreased expression of TNFSF10 protein | decreases expression | 16531263
|
D013876 |
Thiophenes |
Thiophenes analog promotes the reaction [Tretinoin results in increased expression of TNFSF10 mRNA] | increases expression|increases reaction | 16140955
|
D014028 |
Tobacco Smoke Pollution |
Tobacco Smoke Pollution results in increased expression of TNFSF10 mRNA | increases expression | 16137721
|
D014212 |
Tretinoin |
TGFB1 protein inhibits the reaction [Tretinoin results in increased expression of TNFSF10 protein] | decreases reaction|increases expression | 16242776
|
D014212 |
Tretinoin |
Thiophenes analog promotes the reaction [Tretinoin results in increased expression of TNFSF10 mRNA] | increases expression|increases reaction | 16140955
|
D014212 |
Tretinoin |
Tretinoin promotes the reaction [IFNG protein promotes the reaction [IRF1 protein results in increased expression of TNFSF10 mRNA]] | increases expression|increases reaction | 16085646
|
D014212 |
Tretinoin |
Tretinoin promotes the reaction [IFNG protein results in increased expression of TNFSF10 mRNA] | increases expression|increases reaction | 16085646
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of TNFSF10 mRNA | increases expression | 16140955
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of TNFSF10 protein | increases expression | 16242776
|
D014303 |
Trinitrotoluene |
Trinitrotoluene affects the expression of TNFSF10 mRNA | affects expression | 21346803
|
D014415 |
Tunicamycin |
Tunicamycin results in decreased expression of TNFSF10 mRNA | decreases expression | 17127020
|
D014807 |
Vitamin D |
Vitamin D affects the expression of TNFSF10 mRNA | affects expression | 20368581
|
D014810 |
Vitamin E |
Vitamin E results in decreased expression of TNFSF10 mRNA | decreases expression | 19244175
|
C111237 |
vorinostat |
TNFSF10 protein promotes the reaction [vorinostat results in decreased expression of BIRC5 protein] | decreases expression|increases reaction | 17410615
|
C111237 |
vorinostat |
TNFSF10 protein promotes the reaction [vorinostat results in decreased expression of XIAP protein] | decreases expression|increases reaction | 17410615
|
C111237 |
vorinostat |
TNFSF10 protein promotes the reaction [vorinostat results in increased cleavage of and results in increased activity of CASP3 protein] | increases activity|increases cleavage|increases reaction | 17410615
|
C111237 |
vorinostat |
TNFSF10 protein promotes the reaction [vorinostat results in increased cleavage of and results in increased activity of CASP8 protein] | increases activity|increases cleavage|increases reaction | 17410615
|
C111237 |
vorinostat |
TNFSF10 protein promotes the reaction [vorinostat results in increased cleavage of BID protein] | increases cleavage|increases reaction | 17410615
|
C111237 |
vorinostat |
vorinostat results in increased expression of TNFSF10 protein | increases expression | 17410615
|
D015215 |
Zidovudine |
[Zidovudine co-treated with IFNA1 protein] results in increased expression of TNFSF10 mRNA | affects cotreatment|increases expression | 20370541
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Ethanol |
17.98 | 18926900 17676605 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Phenobarbital |
17.98 | 6195326 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
17.98 | 11752688 14514962 15322242 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Thalidomide |
17.98 | 8333272 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Trinitrotoluene |
17.98 | 7525203 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
7.70 | 18287403 |
MESH:D000138 |
Acidosis |
|
Ethanol |
7.70 | 11192467 |
MESH:D000163 |
Acquired Immunodeficiency Syndrome |
|
Zidovudine |
4.01 | 9612607 |
MESH:D058186 |
Acute Kidney Injury |
|
Cisplatin |
6.38 | 15814532 12690470 17670903 |
MESH:D058186 |
Acute Kidney Injury |
|
resveratrol |
6.38 | 16538975 |
MESH:D000230 |
Adenocarcinoma |
|
arsenic trioxide |
19.18 | 11798837 19825857 |
MESH:D000230 |
Adenocarcinoma |
|
Cisplatin |
19.18 | 17638652 11798837 |
MESH:D000230 |
Adenocarcinoma |
|
Dimethylnitrosamine |
19.18 | 16033868 |
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
19.18 | 17418594 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
19.18 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Fenretinide |
19.18 | 10697514 |
MESH:D000230 |
Adenocarcinoma |
|
Fluorouracil |
19.18 | 17638652 |
MESH:D000230 |
Adenocarcinoma |
|
Genistein |
19.18 | 11473722 |
MESH:D002282 |
Adenocarcinoma, Bronchiolo-Alveolar |
|
Tobacco Smoke Pollution |
4.68 | 15814487 |
MESH:D000236 |
Adenoma |
|
4,4'-diaminodiphenylmethane |
11.44 | 3712494 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
11.44 | 10737359 6695378 |
MESH:D000236 |
Adenoma |
|
Dimethylnitrosamine |
11.44 | 19555203 |
MESH:D000236 |
Adenoma |
|
resveratrol |
11.44 | 15688382 |
MESH:D018248 |
Adenoma, Liver Cell |
|
dicyclanil |
18.14 | 17162532 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
18.14 | 19061943 17620307 19052882 17162532 18056438 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Phenobarbital |
18.14 | 17620307 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
18.14 | 16835633 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
3.85 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
Arsenic |
10.96 | 17306315 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
10.96 | 17306315 16712894 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
3.74 | 21441931 |
MESH:D020268 |
Alcohol-Induced Disorders, Nervous System |
|
Ethanol |
4.46 | 15451039 15451040 |
MESH:D019973 |
Alcohol-Related Disorders |
|
Curcumin |
4.23 | 17887948 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
2.92 | 15955085 |
MESH:D019896 |
alpha 1-Antitrypsin Deficiency |
|
Iron |
4.81 | 16640825 |
MESH:D000544 |
Alzheimer Disease |
|
Curcumin |
9.45 | 15590663 |
MESH:D000544 |
Alzheimer Disease |
|
Iron |
9.45 | 16563566 16640825 |
MESH:D000544 |
Alzheimer Disease |
|
Ozone |
9.45 | 15513908 |
MESH:D000544 |
Alzheimer Disease |
|
resveratrol |
9.45 | 16183991 16162502 |
MESH:D000544 |
Alzheimer Disease |
|
sulindac sulfide |
9.45 | 18759972 |
MESH:D000686 |
Amyloidosis |
|
Diethylstilbestrol |
3.68 | 15469931 |
MESH:D000690 |
Amyotrophic Lateral Sclerosis |
|
Thalidomide |
3.77 | 16510725 |
MESH:D000740 |
Anemia |
|
Fluorouracil |
10.61 | 17963324 15504547 16511603 |
MESH:D000740 |
Anemia |
|
Iron |
10.61 | 16566752 16434484 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
10.61 | 11748828 |
MESH:D000743 |
Anemia, Hemolytic |
|
Quercetin |
3.48 | 17084956 |
MESH:D018798 |
Anemia, Iron-Deficiency |
|
Iron |
3.90 | 17375513 17162259 17163184 17147795 16569441 |
MESH:D000756 |
Anemia, Sideroblastic |
|
Iron |
4.05 | 16910769 |
MESH:D000853 |
Anophthalmos |
|
Ethanol |
4.00 | 15513904 |
MESH:D001005 |
Anus Neoplasms |
|
Dacarbazine |
5.44 | 12170190 |
MESH:D001008 |
Anxiety Disorders |
|
Ethanol |
3.32 | 11141031 |
MESH:D001145 |
Arrhythmias, Cardiac |
|
Iron |
3.64 | 16604332 |
MESH:D020261 |
Arsenic Poisoning |
|
Arsenic |
2.56 | 12569548 18414634 16835338 16251483 |
MESH:D001161 |
Arteriosclerosis |
|
Dietary Fats |
3.08 | 15238619 |
MESH:D001169 |
Arthritis, Experimental |
|
Dexamethasone |
12.84 | 17659584 |
MESH:D001169 |
Arthritis, Experimental |
|
resveratrol |
12.84 | 17115116 |
MESH:D001169 |
Arthritis, Experimental |
|
Thalidomide |
12.84 | 9598899 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
12.84 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Curcumin |
8.13 | 16807698 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Ozone |
8.13 | 15570426 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tobacco Smoke Pollution |
8.13 | 19898480 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
8.13 | 16292516 |
MESH:D001249 |
Asthma |
|
epigallocatechin gallate |
8.37 | 16516891 |
MESH:D001249 |
Asthma |
|
Mustard Gas |
8.37 | 10378619 |
MESH:D001249 |
Asthma |
|
Ozone |
8.37 | 16373670 17854713 |
MESH:D001249 |
Asthma |
|
Tretinoin |
8.37 | 16456186 |
MESH:D001260 |
Ataxia Telangiectasia |
|
Iron |
10.33 | 15336622 |
MESH:D001260 |
Ataxia Telangiectasia |
|
Quercetin |
10.33 | 15336622 |
MESH:D050197 |
Atherosclerosis |
|
Arsenic |
18.39 | 12928151 19371607 |
MESH:D050197 |
Atherosclerosis |
|
Cadmium |
18.39 | 15687053 |
MESH:D050197 |
Atherosclerosis |
|
Cholesterol |
18.39 | 16632123 |
MESH:D050197 |
Atherosclerosis |
|
Curcumin |
18.39 | 18704882 |
MESH:D050197 |
Atherosclerosis |
|
Iron |
18.39 | 16632123 16640825 |
MESH:D050197 |
Atherosclerosis |
|
resveratrol |
18.39 | 17967414 16873680 |
MESH:D001321 |
Autistic Disorder |
|
Iron |
2.69 | 17352947 |
MESH:D001321 |
Autistic Disorder |
|
Mercury |
2.69 | 17497416 |
MESH:D001327 |
Autoimmune Diseases |
|
Curcumin |
19.14 | 19761891 |
MESH:D001327 |
Autoimmune Diseases |
|
epigallocatechin gallate |
19.14 | 19761891 |
MESH:D001327 |
Autoimmune Diseases |
|
Mercury |
19.14 | 16634805 |
MESH:D001327 |
Autoimmune Diseases |
|
Quercetin |
19.14 | 19761891 |
MESH:D001424 |
Bacterial Infections |
|
Iron |
4.36 | 16640825 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
3.60 | 16935849 |
MESH:D001660 |
Biliary Tract Diseases |
|
4,4'-diaminodiphenylmethane |
4.16 | 11289319 1440618 |
MESH:D001768 |
Blister |
|
Mustard Gas |
4.32 | 19167455 |
MESH:D001778 |
Blood Coagulation Disorders |
|
arsenic trioxide |
10.96 | 16206674 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
10.96 | 12125929 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
10.96 | 16197459 16206674 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
2.94 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.17 | 15746008 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Cisplatin |
9.23 | 14601052 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
9.23 | 14601052 |
MESH:D020201 |
Brain Hemorrhage, Traumatic |
|
Progesterone |
4.48 | 17868700 |
MESH:D001930 |
Brain Injuries |
|
Progesterone |
3.44 | 15665606 15380490 15845082 |
MESH:D002545 |
Brain Ischemia |
|
beta Carotene |
12.39 | 16157235 |
MESH:D002545 |
Brain Ischemia |
|
Curcumin |
12.39 | 16770732 |
MESH:D002545 |
Brain Ischemia |
|
resveratrol |
12.39 | 17600658 |
MESH:D001932 |
Brain Neoplasms |
|
Curcumin |
10.52 | 17596214 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
10.52 | 17150277 |
MESH:D001932 |
Brain Neoplasms |
|
Fenretinide |
10.52 | 16187019 |
MESH:D001943 |
Breast Neoplasms |
|
alitretinoin |
24.77 | 16344269 |
MESH:D001943 |
Breast Neoplasms |
|
Ascorbic Acid |
24.77 | 16443354 |
MESH:D001943 |
Breast Neoplasms |
|
Chromium |
24.77 | 15986119 |
MESH:D001943 |
Breast Neoplasms |
|
Cisplatin |
24.77 | 18382427 19526202 |
MESH:D001943 |
Breast Neoplasms |
|
Curcumin |
24.77 | 16243823 19250217 18462866 18593918 |
MESH:D001943 |
Breast Neoplasms |
|
Dacarbazine |
24.77 | 17983394 |
MESH:D001943 |
Breast Neoplasms |
|
decitabine |
24.77 | 19208741 18320071 |
MESH:D001943 |
Breast Neoplasms |
|
Dietary Fats |
24.77 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
24.77 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylstilbestrol |
24.77 | 17129689 15324884 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
24.77 | 18628466 17426702 16096432 18382427 16115903 16595493 19526202 17369602 11325840 15993339 18695136 15136595 15692762 17983394 15668708 16264153 15567936 15939500 16935488 15994142 18234424 15634643 16322301 16826403 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
24.77 | 19861407 17261762 17289903 16675129 18497071 14630087 17018787 12948864 |
MESH:D001943 |
Breast Neoplasms |
|
Fenretinide |
24.77 | 16601279 |
MESH:D001943 |
Breast Neoplasms |
|
Fluorouracil |
24.77 | 18357371 16595493 16110121 16557594 19217205 18608205 15136595 |
MESH:D001943 |
Breast Neoplasms |
|
Genistein |
24.77 | 17200150 16541309 16873071 |
MESH:D001943 |
Breast Neoplasms |
|
Nordihydroguaiaretic Acid |
24.77 | 18418215 |
MESH:D001943 |
Breast Neoplasms |
|
Progesterone |
24.77 | 15562024 16175315 17614352 |
MESH:D001943 |
Breast Neoplasms |
|
Quercetin |
24.77 | 18628248 |
MESH:D001943 |
Breast Neoplasms |
|
resveratrol |
24.77 | 17651959 16393696 17534123 |
MESH:D001943 |
Breast Neoplasms |
|
selenomethylselenocysteine |
24.77 | 18855134 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
24.77 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
24.77 | 16166294 16443354 16873071 |
MESH:D001943 |
Breast Neoplasms |
|
vorinostat |
24.77 | 16144943 |
MESH:D016535 |
Bronchial Hyperreactivity |
|
Ozone |
2.99 | 14754758 18417511 15516495 18315731 16777450 19059883 17626835 |
MESH:D001989 |
Bronchiolitis Obliterans |
|
Mustard Gas |
4.32 | 15286001 |
MESH:D001991 |
Bronchitis |
|
Antimony |
5.28 | 8768112 |
MESH:D029481 |
Bronchitis, Chronic |
|
Mustard Gas |
4.12 | 10378619 17687719 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
3.75 | 16813970 |
MESH:D019121 |
Burkholderia Infections |
|
orlistat |
5.79 | 17874328 |
MESH:D002051 |
Burkitt Lymphoma |
|
arsenic trioxide |
3.55 | 11589617 |
MESH:D002056 |
Burns |
|
Ethanol |
3.83 | 16374292 |
MESH:D002100 |
Cachexia |
|
Ozone |
3.90 | 16183385 |
MESH:D002105 |
Cadmium Poisoning |
|
Quercetin |
4.69 | 16962696 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
3.62 | 16111702 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Carbon Tetrachloride |
7.23 | 15673190 15721981 16011737 16124888 10355542 18705752 16050911 15700767 16227642 16097048 3786805 16192424 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Vitamin E |
7.23 | 16050911 |
MESH:D002276 |
Carcinoid Tumor |
|
Dacarbazine |
16.40 | 16051944 |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
16.40 | 16051944 |
MESH:D002276 |
Carcinoid Tumor |
|
Fluorouracil |
16.40 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Curcumin |
14.31 | 18593918 |
MESH:D002277 |
Carcinoma |
|
Dimethylnitrosamine |
14.31 | 19555203 |
MESH:D002277 |
Carcinoma |
|
Fluorouracil |
14.31 | 17121937 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
14.31 | 16835633 |
MESH:D002280 |
Carcinoma, Basal Cell |
|
Arsenic |
3.05 | 15504454 17687452 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
4.30 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
4,4'-diaminodiphenylmethane |
48.39 | 7296757 3581430 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Arsenic |
48.39 | 17306315 16507464 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
arsenic trioxide |
48.39 | 16217749 15073043 11135700 15553829 14691202 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Carbon Tetrachloride |
48.39 | 18788625 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Cisplatin |
48.39 | 17982673 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
dicyclanil |
48.39 | 17162532 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
48.39 | 17055752 19539802 18056438 19052882 16502159 17173139 18971187 20084675 18788625 20007298 20432363 19394651 16935385 18494052 16328049 19335982 19208518 3581430 10672840 20524982 20727157 16830150 19919837 19519916 18665156 19171122 18691550 19701751 16681979 18506893 16878318 18210153 19418558 18785209 20514400 17978847 10737359 19383236 16569478 19107877 20214788 18393292 16807293 16540662 16288022 20935162 16779866 20101231 20512989 16698587 17428255 3084413 17138121 17162532 17761372 19822196 11831363 21159647 18978308 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylstilbestrol |
48.39 | 16924424 15948411 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
48.39 | 16234567 17876044 16023760 18059187 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
48.39 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Ethanol |
48.39 | 15763234 18788625 15289165 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Fenretinide |
48.39 | 17159502 16270382 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Fluorouracil |
48.39 | 18930000 17971768 16799960 17088986 16332177 17045692 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Genistein |
48.39 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Phenobarbital |
48.39 | 17173139 1701930 20935162 6705139 20007298 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Quercetin |
48.39 | 19519916 12508355 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
resveratrol |
48.39 | 19321006 16227395 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
48.39 | 16507464 17306315 15276417 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Thalidomide |
48.39 | 16313753 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
48.39 | 1917145 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
resveratrol |
3.76 | 16675471 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
bortezomib |
12.67 | 16052434 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
Cisplatin |
12.67 | 12023789 16685392 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
Curcumin |
12.67 | 18414057 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
sulindac sulfide |
12.67 | 12391285 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
Tobacco Smoke Pollution |
12.67 | 11212258 |
MESH:D021441 |
Carcinoma, Pancreatic Ductal |
|
Quercetin |
4.13 | 17234771 |
MESH:D002291 |
Carcinoma, Papillary |
|
arsenic trioxide |
4.02 | 19014326 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
4,4'-diaminodiphenylmethane |
11.46 | 7296757 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Dacarbazine |
11.46 | 16201981 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
11.46 | 1485588 16201981 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Fluorouracil |
11.46 | 18695887 |
MESH:D018288 |
Carcinoma, Small Cell |
|
arsenic trioxide |
3.37 | 12490120 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Acetylcysteine |
38.07 | 17015178 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Arsenic |
38.07 | 17687452 18922899 15504454 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Cisplatin |
38.07 | 18337622 6189445 17066447 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Curcumin |
38.07 | 18462866 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
decitabine |
38.07 | 19215824 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Dimethylnitrosamine |
38.07 | 16033868 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
38.07 | 6189445 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Fenretinide |
38.07 | 16274795 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Fluorouracil |
38.07 | 17066447 18986760 16757204 16280240 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
resveratrol |
38.07 | 16227395 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
38.07 | 18572023 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tobacco Smoke Pollution |
38.07 | 11212258 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
38.07 | 16051514 16096774 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Amiloride |
7.57 | 14644129 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Arsenic |
7.57 | 18640142 |
MESH:D006332 |
Cardiomegaly |
|
Ethanol |
8.32 | 19332462 |
MESH:D006332 |
Cardiomegaly |
|
Quercetin |
8.32 | 19794523 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
8.32 | 18670907 18850075 16120746 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
6.14 | 16952015 17329180 17924179 17131338 17928571 17519947 15811867 17007740 15792986 18627295 16269455 15476868 16109756 16455267 17974986 17308081 16731534 17351982 16278810 16651473 17382496 16612575 15505089 16242529 16364871 |
MESH:D009202 |
Cardiomyopathies |
|
Iron |
6.14 | 16640825 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Antimony |
10.48 | 10334427 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
10.48 | 17334414 16243910 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Iron |
10.48 | 16604332 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Mercury |
10.48 | 10334427 |
MESH:D002318 |
Cardiovascular Diseases |
|
Arsenic |
8.62 | 19152805 15738583 17938729 |
MESH:D002318 |
Cardiovascular Diseases |
|
Genistein |
8.62 | 16332659 |
MESH:D002318 |
Cardiovascular Diseases |
|
resveratrol |
8.62 | 15458977 |
MESH:D002340 |
Carotid Artery Diseases |
|
Arsenic |
3.58 | 16973168 18022660 |
MESH:D002386 |
Cataract |
|
Tretinoin |
5.82 | 17460283 |
MESH:D002386 |
Cataract |
|
Trinitrotoluene |
5.82 | 15817613 14694615 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
4,4'-diaminodiphenylmethane |
26.42 | 7505956 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Acetylcysteine |
26.42 | 18226522 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cadmium |
26.42 | 17332340 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
26.42 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cytarabine |
26.42 | 8243401 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
26.42 | 7505956 17174075 2727394 21159647 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
26.42 | 18566989 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
26.42 | 19524636 20056578 |
MESH:D002493 |
Central Nervous System Diseases |
|
Phenobarbital |
3.43 | 4080065 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Fenretinide |
10.20 | 16154183 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
10.20 | 16129372 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
12.01 | 19052882 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
12.01 | 16835633 |
MESH:D018281 |
Cholangiocarcinoma |
|
Thalidomide |
12.01 | 18291259 |
MESH:D002779 |
Cholestasis |
|
4,4'-diaminodiphenylmethane |
5.68 | 9022650 19486331 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
5.68 | 19486331 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
4.30 | 16461808 |
MESH:D019457 |
Chromosome Breakage |
|
Sodium Selenite |
3.93 | 15894690 |
MESH:D002916 |
Chylothorax |
|
orlistat |
5.79 | 17003701 |
MESH:D002971 |
Cleft Lip |
|
Ethanol |
3.07 | 15513904 |
MESH:D002972 |
Cleft Palate |
|
Ethanol |
7.25 | 15513904 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
7.25 | 15668235 16354765 15340226 12621046 8697196 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
7.25 | 9407595 |
MESH:D003092 |
Colitis |
|
Amiloride |
26.72 | 12065299 |
MESH:D003092 |
Colitis |
|
Curcumin |
26.72 | 16782535 18200517 16804969 |
MESH:D003092 |
Colitis |
|
resveratrol |
26.72 | 16474422 |
MESH:D003092 |
Colitis |
|
Selenium |
26.72 | 17936198 |
MESH:D003092 |
Colitis |
|
Thalidomide |
26.72 | 16680017 |
MESH:D003092 |
Colitis |
|
Tretinoin |
26.72 | 17035595 |
MESH:D003103 |
Coloboma |
|
Curcumin |
3.78 | 18809619 |
MESH:D003110 |
Colonic Neoplasms |
therapeutic |
|
| 15993848 |
MESH:D003110 |
Colonic Neoplasms |
|
17-(allylamino)-17-demethoxygeldanamycin |
31.58 | 15993848 |
MESH:D003110 |
Colonic Neoplasms |
|
Curcumin |
31.58 | 19359593 16340194 |
MESH:D003110 |
Colonic Neoplasms |
|
decitabine |
31.58 | 17616700 |
MESH:D003110 |
Colonic Neoplasms |
|
Dexamethasone |
31.58 | 15824018 |
MESH:D003110 |
Colonic Neoplasms |
|
Fluorouracil |
31.58 | 17172411 18772588 17169374 17725105 17018589 16510598 16340194 15001691 17016597 17287894 |
MESH:D003110 |
Colonic Neoplasms |
|
Genistein |
31.58 | 17182828 |
MESH:D003110 |
Colonic Neoplasms |
|
irinotecan |
31.58 | 17287894 17725105 |
MESH:D003110 |
Colonic Neoplasms |
|
Iron |
31.58 | 16640825 |
MESH:D003110 |
Colonic Neoplasms |
|
Nordihydroguaiaretic Acid |
31.58 | 15936596 |
MESH:D003110 |
Colonic Neoplasms |
|
oxaliplatin |
31.58 | 16004971 16024531 16510598 |
MESH:D003110 |
Colonic Neoplasms |
|
polyphenols |
31.58 | 16293270 |
MESH:D003110 |
Colonic Neoplasms |
|
Quercetin |
31.58 | 11134977 17148506 19056647 15741050 17191121 16640504 19440933 |
MESH:D003110 |
Colonic Neoplasms |
|
resveratrol |
31.58 | 16338953 |
MESH:D015179 |
Colorectal Neoplasms |
therapeutic |
|
| 17273769 |
MESH:D015179 |
Colorectal Neoplasms |
|
arsenic trioxide |
16.52 | 20501625 |
MESH:D015179 |
Colorectal Neoplasms |
|
Cisplatin |
16.52 | 15273666 |
MESH:D015179 |
Colorectal Neoplasms |
|
Dacarbazine |
16.52 | 15273666 |
MESH:D015179 |
Colorectal Neoplasms |
|
decitabine |
16.52 | 18981723 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
16.52 | 18259882 18802399 |
MESH:D015179 |
Colorectal Neoplasms |
|
Fenretinide |
16.52 | 17273769 |
MESH:D015179 |
Colorectal Neoplasms |
|
Fluorouracil |
16.52 | 20501625 16331619 18802399 17016601 16524972 18288408 16282729 18949393 17695437 18383874 17454858 14970324 17094418 15148649 18509181 17594712 17255274 16303861 17401013 15289873 16391804 18448328 |
MESH:D015179 |
Colorectal Neoplasms |
|
irinotecan |
16.52 | 16391804 18259882 16303861 17454858 18509181 15273666 17159606 |
MESH:D015179 |
Colorectal Neoplasms |
|
oxaliplatin |
16.52 | 17255274 17695437 17594712 18448328 17401013 18509181 |
MESH:D015179 |
Colorectal Neoplasms |
|
Quercetin |
16.52 | 18095365 18852136 |
MESH:D015179 |
Colorectal Neoplasms |
|
resveratrol |
16.52 | 16550006 |
MESH:D003139 |
Common Cold |
|
Ascorbic Acid |
4.62 | 17323712 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
6.87 | 14669216 17141729 |
MESH:D000013 |
Congenital Abnormalities |
|
Trinitrotoluene |
6.87 | 15095906 |
MESH:D016510 |
Corneal Neovascularization |
|
Curcumin |
9.89 | 18497527 |
MESH:D016510 |
Corneal Neovascularization |
|
Thalidomide |
9.89 | 9301478 |
MESH:D003327 |
Coronary Disease |
|
resveratrol |
3.16 | 16507316 |
MESH:D023903 |
Coronary Restenosis |
|
arsenic trioxide |
3.38 | 12609071 |
MESH:D003389 |
Cranial Nerve Diseases |
|
Thalidomide |
5.45 | 9200351 |
MESH:D019465 |
Craniofacial Abnormalities |
|
arsenic trioxide |
11.34 | 10525206 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Dexamethasone |
11.34 | 17728286 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Ethanol |
11.34 | 10194807 15513904 11873399 15451039 11198716 19302082 15451040 |
MESH:D019465 |
Craniofacial Abnormalities |
|
lead acetate |
11.34 | 19769572 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
11.34 | 15322242 20055451 10048152 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Thalidomide |
11.34 | 9200351 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
11.34 | 16925845 10589399 8800419 17551590 14991402 9125849 9142499 9211117 9664655 9224671 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Vitamin E |
11.34 | 19769572 |
MESH:D003424 |
Crohn Disease |
|
Thalidomide |
3.68 | 16078585 |
MESH:D003456 |
Cryptorchidism |
|
Diethylstilbestrol |
3.76 | 16002989 12952375 |
MESH:D003490 |
Cyanosis |
|
Trinitrotoluene |
4.10 | 18551238 |
MESH:D003550 |
Cystic Fibrosis |
|
Acetylcysteine |
3.65 | 19747007 |
MESH:D007644 |
Darier Disease |
|
Fluorouracil |
3.95 | 16733453 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
arsenic trioxide |
3.31 | 15213294 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
4,4'-diaminodiphenylmethane |
10.09 | 8970840 11906362 11298694 8156756 18759878 14531868 12868966 2524372 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
Dexamethasone |
10.09 | 12438553 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
Mercury |
10.09 | 16823706 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
Potassium Dichromate |
10.09 | 16823706 |
MESH:D003877 |
Dermatitis, Contact |
|
4,4'-diaminodiphenylmethane |
2.72 | 3621924 2952479 |
MESH:D048909 |
Diabetes Complications |
|
orlistat |
4.99 | 19207292 |
MESH:D018500 |
Diabetes Insipidus, Nephrogenic |
|
17-(allylamino)-17-demethoxygeldanamycin |
5.43 | 18854434 |
MESH:D003920 |
Diabetes Mellitus |
|
Iron |
7.07 | 16640825 16604332 |
MESH:D003920 |
Diabetes Mellitus |
|
Sodium Selenite |
7.07 | 16285004 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
Quercetin |
6.22 | 19496084 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
resveratrol |
6.22 | 16873680 |
MESH:D003922 |
Diabetes Mellitus, Type 1 |
|
Iron |
3.03 | 16506275 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Ascorbic Acid |
16.23 | 16506275 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Curcumin |
16.23 | 18403477 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
16.23 | 20387270 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
epigallocatechin gallate |
16.23 | 16988119 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Genistein |
16.23 | 16647724 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Iron |
16.23 | 16506275 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
16.23 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Curcumin |
10.91 | 18204486 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
10.91 | 19279558 |
MESH:D003928 |
Diabetic Nephropathies |
|
resveratrol |
10.91 | 16286809 |
MESH:D003929 |
Diabetic Neuropathies |
|
Progesterone |
3.67 | 17187935 |
MESH:D003967 |
Diarrhea |
|
Dexamethasone |
9.10 | 7237001 |
MESH:D003967 |
Diarrhea |
|
orlistat |
9.10 | 20002075 |
MESH:D003967 |
Diarrhea |
|
vorinostat |
9.10 | 20479100 |
MESH:D004283 |
Dog Diseases |
|
Antimony |
4.82 | 12019027 |
MESH:D004342 |
Drug Hypersensitivity |
|
Dacarbazine |
4.38 | 16508601 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4,4'-diaminodiphenylmethane |
34.78 | 16192314 11289319 6679447 18692083 7440962 18648102 18289764 8291058 9328219 6482804 9022650 9653073 1440618 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetylcysteine |
34.78 | 11287661 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbon Tetrachloride |
34.78 | 15998439 16227642 4309450 10092053 19336974 6884620 3786805 10915739 11566570 15027814 3732212 21278145 7120509 7179309 15968718 9327722 17522070 2869522 6623471 19085960 16177239 7440962 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Chlorodiphenyl (54% Chlorine) |
34.78 | 17851650 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
34.78 | 19107877 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Dimethylformamide |
34.78 | 3732212 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Dimethylnitrosamine |
34.78 | 8172417 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
34.78 | 17416283 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Ethanol |
34.78 | 11566570 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
polyphenols |
34.78 | 19370779 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Selenium |
34.78 | 15131321 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Sodium Selenite |
34.78 | 15131321 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
34.78 | 20420201 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Trinitrotoluene |
34.78 | 21346803 18551238 |
MESH:D004362 |
Drug Toxicity |
|
Cisplatin |
14.25 | 12649298 19839026 15033597 12231392 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
14.25 | 18602426 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
14.25 | 11462148 |
MESH:D004362 |
Drug Toxicity |
|
Zidovudine |
14.25 | 15040536 |
MESH:D004381 |
Duodenal Ulcer |
|
Curcumin |
3.26 | 17351913 |
MESH:D050171 |
Dyslipidemias |
|
Dietary Fats |
2.81 | 18367378 |
MESH:D004417 |
Dyspnea |
|
Furosemide |
4.10 | 16935035 |
MESH:D004421 |
Dystonia |
|
Phenobarbital |
3.22 | 1851702 |
MESH:C538011 |
Eales disease |
|
Ascorbic Acid |
10.24 | 9068938 |
MESH:C538011 |
Eales disease |
|
Vitamin E |
10.24 | 9068938 |
MESH:D004485 |
Eczema |
|
Dexamethasone |
3.66 | 12438553 |
MESH:D004487 |
Edema |
|
Dexamethasone |
13.80 | 19703484 |
MESH:D004487 |
Edema |
|
Furosemide |
13.80 | 11834646 |
MESH:D004487 |
Edema |
|
Mustard Gas |
13.80 | 11402378 11428631 9260866 11428647 |
MESH:D004487 |
Edema |
|
resveratrol |
13.80 | 8985016 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
13.80 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
9.12 | 16714409 18230668 15322242 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
9.12 | 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Progesterone |
6.71 | 17692515 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
resveratrol |
6.71 | 17872969 |
MESH:D004701 |
Endocrine Gland Neoplasms |
|
decitabine |
4.26 | 19294695 |
MESH:D004714 |
Endometrial Hyperplasia |
|
Diethylstilbestrol |
9.12 | 16402032 |
MESH:D004714 |
Endometrial Hyperplasia |
|
Genistein |
9.12 | 16402032 |
MESH:D016889 |
Endometrial Neoplasms |
|
Diethylstilbestrol |
16.96 | 15700306 16804899 |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
16.96 | 17359293 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
16.96 | 18566989 19148513 11473722 |
MESH:D016889 |
Endometrial Neoplasms |
|
Genistein |
16.96 | 11473722 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
16.96 | 16569247 |
MESH:D004715 |
Endometriosis |
|
Progesterone |
6.47 | 16134523 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
6.47 | 10568697 9294722 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
4.30 | 18037988 |
MESH:D020345 |
Enterocolitis, Necrotizing |
|
resveratrol |
4.03 | 17923197 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Phenobarbital |
3.29 | 3659116 |
MESH:D004828 |
Epilepsies, Partial |
|
Phenobarbital |
3.03 | 3922381 11558140 |
MESH:D004827 |
Epilepsy |
|
Phenobarbital |
2.39 | 20417680 |
MESH:D004832 |
Epilepsy, Absence |
|
Phenobarbital |
2.82 | 6401628 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Phenobarbital |
3.43 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Phenobarbital |
3.19 | 3659116 |
MESH:D004890 |
Erythema |
|
Mustard Gas |
4.32 | 9357497 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
4.26 | 16302075 |
MESH:D004938 |
Esophageal Neoplasms |
|
4,4'-diaminodiphenylmethane |
13.31 | 3581430 |
MESH:D004938 |
Esophageal Neoplasms |
|
arsenic trioxide |
13.31 | 12903497 |
MESH:D004938 |
Esophageal Neoplasms |
|
Cisplatin |
13.31 | 17638652 15173087 15464296 16785472 16481741 |
MESH:D004938 |
Esophageal Neoplasms |
|
Dimethylnitrosamine |
13.31 | 17016578 |
MESH:D004938 |
Esophageal Neoplasms |
|
Ethanol |
13.31 | 16704527 |
MESH:D004938 |
Esophageal Neoplasms |
|
Fluorouracil |
13.31 | 16481741 16337965 16785472 17638652 15173087 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
6.62 | 11564622 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
6.62 | 9664655 16938888 |
MESH:D005221 |
Fatigue |
|
vorinostat |
4.76 | 20479100 |
MESH:D005234 |
Fatty Liver |
|
arsenic trioxide |
34.96 | 15073043 |
MESH:D005234 |
Fatty Liver |
|
Carbon Tetrachloride |
34.96 | 61145 17595544 12631006 16239168 19224547 15959796 16045604 12795759 |
MESH:D005234 |
Fatty Liver |
|
Curcumin |
34.96 | 19297423 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
34.96 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Dietary Fats |
34.96 | 18296743 19551842 17967931 19004024 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
34.96 | 20387270 21071580 |
MESH:D005234 |
Fatty Liver |
|
Ethanol |
34.96 | 19236843 18620774 16409862 |
MESH:D005234 |
Fatty Liver |
|
Iron |
34.96 | 16640825 |
MESH:D005234 |
Fatty Liver |
|
Zidovudine |
34.96 | 18299183 |
MESH:D005235 |
Fatty Liver, Alcoholic |
|
Ethanol |
4.81 | 17920746 |
MESH:D052776 |
Female Urogenital Diseases |
|
Diethylstilbestrol |
3.08 | 16611131 15751030 16534752 16002989 16513791 |
MESH:D005310 |
Fetal Alcohol Syndrome |
|
Ethanol |
4.46 | 15451040 15513904 10194807 16946407 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
2.64 | 11858732 |
MESH:D005317 |
Fetal Growth Retardation |
|
lead acetate |
4.58 | 19769572 |
MESH:D005350 |
Fibroma |
|
4,4'-diaminodiphenylmethane |
4.16 | 6705139 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Dacarbazine |
9.31 | 19069698 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
9.31 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Carbon Tetrachloride |
29.14 | 18705752 |
MESH:D005355 |
Fibrosis |
|
Curcumin |
29.14 | 18705752 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
29.14 | 12168785 12639820 |
MESH:D005355 |
Fibrosis |
|
Dietary Fats |
29.14 | 18296743 |
MESH:D005355 |
Fibrosis |
|
Quercetin |
29.14 | 19474275 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
29.14 | 20067830 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
29.14 | 17994277 |
MESH:D005414 |
Flatulence |
|
orlistat |
5.79 | 20002075 |
MESH:D005534 |
Foot Diseases |
|
Arsenic |
4.70 | 6392382 |
MESH:D005621 |
Friedreich Ataxia |
|
Iron |
4.61 | 16640825 16604332 |
MESH:D005706 |
Gallbladder Neoplasms |
|
arsenic trioxide |
3.46 | 16904648 |
MESH:D005756 |
Gastritis |
|
Ethanol |
3.84 | 15046732 |
MESH:D005770 |
Gastrointestinal Neoplasms |
|
Curcumin |
3.87 | 18462866 |
MESH:D005833 |
Genital Neoplasms, Female |
|
Diethylstilbestrol |
10.03 | 16452187 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
10.03 | 16452187 |
MESH:D005871 |
Giant Lymph Node Hyperplasia |
|
Thalidomide |
5.45 | 12701121 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
3.38 | 8708960 |
MESH:D005909 |
Glioblastoma |
|
Curcumin |
28.72 | 17596214 |
MESH:D005909 |
Glioblastoma |
|
Dacarbazine |
28.72 | 12853885 12592361 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
28.72 | 17150277 |
MESH:D005909 |
Glioblastoma |
|
Fenretinide |
28.72 | 16187019 |
MESH:D005909 |
Glioblastoma |
|
Genistein |
28.72 | 16598420 |
MESH:D005909 |
Glioblastoma |
|
Okadaic Acid |
28.72 | 17312396 |
MESH:D005909 |
Glioblastoma |
|
Quercetin |
28.72 | 19804834 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
28.72 | 17312396 |
MESH:D005910 |
Glioma |
|
Fluorouracil |
7.58 | 16145905 |
MESH:D005910 |
Glioma |
|
Quercetin |
7.58 | 17643826 |
MESH:D005910 |
Glioma |
|
Thalidomide |
7.58 | 16327979 |
MESH:D006042 |
Goiter |
|
4,4'-diaminodiphenylmethane |
3.25 | 7505956 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
3.74 | 10696789 |
MESH:D006130 |
Growth Disorders |
|
Amiloride |
4.16 | 19703807 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Cisplatin |
22.17 | 15464296 15102660 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Curcumin |
22.17 | 18462866 18829502 |
MESH:D006258 |
Head and Neck Neoplasms |
|
decitabine |
22.17 | 19215824 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
22.17 | 15692506 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Fluorouracil |
22.17 | 18337622 15102660 15162350 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
22.17 | 16096774 |
MESH:D034381 |
Hearing Loss |
|
Cisplatin |
7.85 | 19898482 |
MESH:D034381 |
Hearing Loss |
|
Furosemide |
7.85 | 17868369 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
4.30 | 16084493 |
MESH:D006319 |
Hearing Loss, Sensorineural |
|
Cisplatin |
3.71 | 15464296 |
MESH:D006330 |
Heart Defects, Congenital |
|
Ascorbic Acid |
11.72 | 16080930 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
11.72 | 10048152 11294989 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
11.72 | 14991402 9664655 |
MESH:D006330 |
Heart Defects, Congenital |
|
Vitamin E |
11.72 | 16080930 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
2.87 | 18006777 16495754 12587719 16244371 17875725 16879835 16244372 18674790 14766674 16707910 17888722 16144979 16330681 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
8.64 | 17481944 |
MESH:D006333 |
Heart Failure |
|
Furosemide |
8.64 | 16845234 16011733 12660669 |
MESH:D006333 |
Heart Failure |
|
Selenium |
8.64 | 17162251 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
3.15 | 15692506 |
MESH:D006402 |
Hematologic Diseases |
|
Zidovudine |
3.93 | 12579204 |
MESH:D006432 |
Hemochromatosis |
|
Iron |
3.84 | 16574947 16640825 17255318 17236123 17053826 16604332 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
3.58 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
2.57 | 11000095 |
MESH:D006486 |
Hemosiderosis |
|
Iron |
4.36 | 16604332 |
MESH:D006505 |
Hepatitis |
|
4,4'-diaminodiphenylmethane |
6.58 | 6705139 |
MESH:D006505 |
Hepatitis |
|
Carbon Tetrachloride |
6.58 | 19110552 19900420 |
MESH:D006525 |
Hepatitis, Viral, Human |
|
Iron |
4.62 | 16640825 |
MESH:D006527 |
Hepatolenticular Degeneration |
|
Iron |
4.12 | 17182432 |
MESH:D006529 |
Hepatomegaly |
|
Iron |
14.14 | 16890145 |
MESH:D006529 |
Hepatomegaly |
|
Phenobarbital |
14.14 | 16109766 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
14.14 | 15340226 12621046 16120746 |
MESH:D006529 |
Hepatomegaly |
|
Trinitrotoluene |
14.14 | 15817613 |
MESH:D015417 |
Hereditary Sensory and Motor Neuropathy |
|
Curcumin |
4.22 | 17701891 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Ascorbic Acid |
7.40 | 16863852 16490937 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Dexamethasone |
7.40 | 7520565 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Vitamin E |
7.40 | 16863852 16490937 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.18 | 15709030 |
MESH:D006561 |
Herpes Simplex |
|
resveratrol |
3.35 | 16876885 |
MESH:D015658 |
HIV Infections |
|
beta Carotene |
8.06 | 16960176 |
MESH:D015658 |
HIV Infections |
|
Iron |
8.06 | 16597321 |
MESH:D015658 |
HIV Infections |
|
Zidovudine |
8.06 | 17358032 11363243 11141242 11698656 20032539 |
MESH:D019247 |
HIV Wasting Syndrome |
|
testosterone enanthate |
4.89 | 17440010 |
MESH:D006689 |
Hodgkin Disease |
|
Cisplatin |
15.42 | 16200630 16170182 |
MESH:D006689 |
Hodgkin Disease |
|
Cytarabine |
15.42 | 16200630 |
MESH:D006689 |
Hodgkin Disease |
|
Dacarbazine |
15.42 | 18501091 16170182 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
15.42 | 18501091 17606976 15147373 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
15.42 | 12676792 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
7.24 | 17088409 |
MESH:D019584 |
Hot Flashes |
|
Vitamin E |
7.24 | 14716179 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.19 | 8697196 18606429 15340226 16959395 16354765 |
MESH:D006930 |
Hyperalgesia |
|
Ethanol |
9.32 | 18783367 |
MESH:D006930 |
Hyperalgesia |
|
oxaliplatin |
9.32 | 17418472 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
9.32 | 16870215 |
MESH:D006932 |
Hyperbilirubinemia |
|
Carbon Tetrachloride |
3.69 | 16899240 |
MESH:D006934 |
Hypercalcemia |
|
bortezomib |
8.91 | 18089816 |
MESH:D006934 |
Hypercalcemia |
|
Furosemide |
8.91 | 17652376 |
MESH:D053565 |
Hypercalciuria |
|
Furosemide |
4.81 | 17652376 |
MESH:D006937 |
Hypercholesterolemia |
|
Cholesterol |
15.68 | 16933029 |
MESH:D006937 |
Hypercholesterolemia |
|
Curcumin |
15.68 | 18704882 |
MESH:D006937 |
Hypercholesterolemia |
|
Dietary Fats |
15.68 | 21332399 |
MESH:D006937 |
Hypercholesterolemia |
|
resveratrol |
15.68 | 17188708 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
3.75 | 16778211 |
MESH:D006943 |
Hyperglycemia |
|
Quercetin |
3.29 | 18262572 11834736 |
MESH:D017488 |
Hyperkeratosis, Epidermolytic |
|
Arsenic |
3.71 | 17050553 |
MESH:D006949 |
Hyperlipidemias |
|
Dietary Fats |
11.15 | 21332399 |
MESH:D006949 |
Hyperlipidemias |
|
orlistat |
11.15 | 21332399 |
MESH:D006949 |
Hyperlipidemias |
|
resveratrol |
11.15 | 16873680 |
MESH:D006962 |
Hyperparathyroidism, Secondary |
|
Furosemide |
5.02 | 15086907 |
MESH:D006965 |
Hyperplasia |
|
4,4'-diaminodiphenylmethane |
8.12 | 15034207 |
MESH:D006965 |
Hyperplasia |
|
Diethylstilbestrol |
8.12 | 14722030 12960047 |
MESH:D006973 |
Hypertension |
|
Amiloride |
15.19 | 18524855 19344079 15174897 |
MESH:D006973 |
Hypertension |
|
Arsenic |
15.19 | 11953799 9931084 16076760 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
15.19 | 10903974 |
MESH:D006973 |
Hypertension |
|
Dexamethasone |
15.19 | 17042910 |
MESH:D006973 |
Hypertension |
|
Quercetin |
15.19 | 18356687 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
15.19 | 18850075 18670907 |
MESH:D006975 |
Hypertension, Portal |
|
Carbon Tetrachloride |
3.27 | 15338365 |
MESH:D046110 |
Hypertension, Pregnancy-Induced |
|
Furosemide |
4.47 | 16612254 |
MESH:D017379 |
Hypertrophy, Left Ventricular |
|
resveratrol |
3.56 | 17488730 |
MESH:D006987 |
Hypesthesia |
|
Arsenic |
4.70 | 16093927 |
MESH:D007006 |
Hypogonadism |
|
Iron |
3.76 | 16640825 |
MESH:D020514 |
Hypokalemic Periodic Paralysis |
|
Amiloride |
5.01 | 19822448 |
MESH:C537153 |
Hypomagnesemia primary |
|
Furosemide |
4.81 | 11041285 |
MESH:D007019 |
Hypoproteinemia |
|
Furosemide |
5.02 | 16096441 |
MESH:D007021 |
Hypospadias |
|
Diethylstilbestrol |
3.76 | 16002989 |
MESH:D007022 |
Hypotension |
|
Furosemide |
7.29 | 11041285 |
MESH:D007022 |
Hypotension |
|
Isoflurane |
7.29 | 12967683 |
MESH:D007024 |
Hypotension, Orthostatic |
|
Furosemide |
4.57 | 15811171 |
MESH:D007037 |
Hypothyroidism |
|
Iron |
4.26 | 16640825 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
Progesterone |
8.77 | 15869954 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
resveratrol |
8.77 | 17600658 |
MESH:D007246 |
Infertility |
|
Diethylstilbestrol |
3.56 | 15036965 |
MESH:D007248 |
Infertility, Male |
|
decitabine |
7.85 | 17581917 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
7.85 | 12646999 15346721 |
MESH:D007248 |
Infertility, Male |
|
Trinitrotoluene |
7.85 | 12150543 |
MESH:D007249 |
Inflammation |
|
Amiloride |
37.46 | 17237260 |
MESH:D007249 |
Inflammation |
|
Curcumin |
37.46 | 17151092 18403477 16956363 |
MESH:D007249 |
Inflammation |
|
Dexamethasone |
37.46 | 11099482 8960868 |
MESH:D007249 |
Inflammation |
|
Dietary Fats |
37.46 | 20412841 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
37.46 | 18785209 |
MESH:D007249 |
Inflammation |
|
Flavonoids |
37.46 | 17296493 |
MESH:D007249 |
Inflammation |
|
Mustard Gas |
37.46 | 17524151 11428631 8975870 11428647 9357497 9260866 11402378 11428620 16001271 |
MESH:D007249 |
Inflammation |
|
polyphenols |
37.46 | 16366677 |
MESH:D007249 |
Inflammation |
|
Progesterone |
37.46 | 15869954 |
MESH:D007249 |
Inflammation |
|
resveratrol |
37.46 | 16366677 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
37.46 | 12200463 12878042 |
MESH:D007249 |
Inflammation |
|
Thalidomide |
37.46 | 16134734 |
MESH:D007249 |
Inflammation |
|
Tobacco Smoke Pollution |
37.46 | 18590791 |
MESH:D015212 |
Inflammatory Bowel Diseases |
|
Curcumin |
2.79 | 18596194 18200517 |
MESH:D007251 |
Influenza, Human |
|
Nordihydroguaiaretic Acid |
26.10 | 18473937 |
MESH:D007251 |
Influenza, Human |
|
Quercetin |
26.10 | 16624496 |
MESH:D007251 |
Influenza, Human |
|
resveratrol |
26.10 | 16624496 |
MESH:D007251 |
Influenza, Human |
|
Selenium |
26.10 | 16624496 |
MESH:D007251 |
Influenza, Human |
|
Vitamin E |
26.10 | 16624496 |
MESH:D007333 |
Insulin Resistance |
|
Dietary Fats |
12.77 | 11836018 18457598 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
12.77 | 16627594 16393666 |
MESH:D007333 |
Insulin Resistance |
|
orlistat |
12.77 | 17201808 |
MESH:D007333 |
Insulin Resistance |
|
Sodium Selenite |
12.77 | 14714311 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
2.96 | 17994277 |
MESH:D007414 |
Intestinal Neoplasms |
|
Curcumin |
3.48 | 10783313 |
MESH:D019189 |
Iron Metabolism Disorders |
|
Iron |
4.25 | 17163184 |
MESH:D007565 |
Jaundice |
|
4,4'-diaminodiphenylmethane |
4.16 | 8074119 9022650 |
MESH:D007569 |
Jaw Abnormalities |
|
Ethanol |
12.78 | 15513904 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
12.78 | 16580747 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
12.78 | 17551590 15992940 |
MESH:D007627 |
Keloid |
|
Quercetin |
4.13 | 17086741 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
3.59 | 15604871 |
MESH:D007642 |
Keratosis |
|
Arsenic |
4.15 | 12749816 16930632 |
MESH:D017492 |
Keratosis, Seborrheic |
|
alitretinoin |
4.80 | 16144296 |
MESH:D007673 |
Kidney Cortex Necrosis |
|
Cisplatin |
4.29 | 15464296 |
MESH:D007674 |
Kidney Diseases |
|
Cadmium |
45.41 | 16962696 16322080 16226777 |
MESH:D007674 |
Kidney Diseases |
|
Cadmium Chloride |
45.41 | 16962696 |
MESH:D007674 |
Kidney Diseases |
|
Chromium |
45.41 | 17934191 |
MESH:D007674 |
Kidney Diseases |
|
Cisplatin |
45.41 | 15190930 18289764 19839026 12231392 12649298 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
45.41 | 8314463 10903974 18776723 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
45.41 | 15369732 15699352 16775033 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
45.41 | 15618244 |
MESH:D007674 |
Kidney Diseases |
|
Furosemide |
45.41 | 11041285 |
MESH:D007674 |
Kidney Diseases |
|
Mercury |
45.41 | 17934191 |
MESH:D007674 |
Kidney Diseases |
|
Potassium Dichromate |
45.41 | 19665454 |
MESH:D007674 |
Kidney Diseases |
|
Quercetin |
45.41 | 16962696 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
45.41 | 20008137 |
MESH:D007674 |
Kidney Diseases |
|
Vitamin E |
45.41 | 12488133 |
MESH:C531755 |
Kidney disorder involving deposition of calcium and oxalate or phosphate in the renal tubules |
|
orlistat |
5.79 | 17185156 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
7.45 | 16707910 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Selenium |
7.45 | 16518626 |
MESH:D007680 |
Kidney Neoplasms |
therapeutic |
|
| 16985049 |
MESH:D007680 |
Kidney Neoplasms |
|
4,4'-diaminodiphenylmethane |
20.08 | 6582329 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
20.08 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Diethylstilbestrol |
20.08 | 15003126 14681315 16762066 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
20.08 | 15610895 |
MESH:D007680 |
Kidney Neoplasms |
|
Fluorouracil |
20.08 | 16985049 |
MESH:D007680 |
Kidney Neoplasms |
|
Zidovudine |
20.08 | 12579204 |
MESH:D007683 |
Kidney Tubular Necrosis, Acute |
|
Cisplatin |
3.94 | 11231351 |
MESH:D007859 |
Learning Disorders |
|
Cholesterol |
11.58 | 17134702 |
MESH:D007859 |
Learning Disorders |
|
Diethylstilbestrol |
11.58 | 17184923 |
MESH:D007859 |
Learning Disorders |
|
Ethanol |
11.58 | 15451040 |
MESH:D007889 |
Leiomyoma |
|
Curcumin |
3.79 | 18555241 |
MESH:D007896 |
Leishmaniasis |
|
Antimony |
4.09 | 12019027 15220340 21063981 10953559 21182181 |
MESH:D016773 |
Leishmaniasis, Cutaneous |
|
Antimony |
3.97 | 8889330 11475954 19141829 |
MESH:D007897 |
Leishmaniasis, Mucocutaneous |
|
Antimony |
4.65 | 10881086 11370249 7854095 9643325 10651420 |
MESH:D007898 |
Leishmaniasis, Visceral |
|
Antimony |
9.59 | 7554475 11105143 7854095 20495762 7875148 8142506 1899875 |
MESH:D007898 |
Leishmaniasis, Visceral |
|
Antimony Potassium Tartrate |
9.59 | 12707265 |
MESH:D007898 |
Leishmaniasis, Visceral |
|
Thalidomide |
9.59 | 16514283 |
MESH:D007938 |
Leukemia |
|
arsenic trioxide |
18.12 | 15070760 |
MESH:D007938 |
Leukemia |
|
Curcumin |
18.12 | 18462866 |
MESH:D007938 |
Leukemia |
|
decitabine |
18.12 | 18980019 19235587 |
MESH:D007938 |
Leukemia |
|
Genistein |
18.12 | 18980019 17468513 |
MESH:D007938 |
Leukemia |
|
Quercetin |
18.12 | 17468513 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
18.12 | 17143497 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
4.30 | 16085563 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
arsenic trioxide |
17.00 | 12560223 17077332 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
bortezomib |
17.00 | 18089816 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
Curcumin |
17.00 | 16106398 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
Zidovudine |
17.00 | 20370541 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
arsenic trioxide |
3.47 | 16972261 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
arsenic trioxide |
2.77 | 14633726 |
MESH:D007951 |
Leukemia, Myeloid |
|
arsenic trioxide |
11.61 | 19077051 |
MESH:D007951 |
Leukemia, Myeloid |
|
decitabine |
11.61 | 18454857 17236224 19117987 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
11.61 | 16482212 16932348 19285840 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
arsenic trioxide |
11.59 | 20471514 19850784 17050201 16968895 16467208 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
bortezomib |
11.59 | 20471514 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
decitabine |
11.59 | 17679729 19387464 18704418 18206229 18460780 19010910 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Thalidomide |
11.59 | 18720364 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
11.59 | 17596541 16294345 19850784 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Vitamin D |
11.59 | 20368581 |
MESH:D015477 |
Leukemia, Myelomonocytic, Chronic |
|
decitabine |
4.61 | 18055864 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Antimony Potassium Tartrate |
21.92 | 9834237 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Arsenic |
21.92 | 17339181 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
arsenic trioxide |
21.92 | 12679006 19642359 15622746 16112521 19225113 16891316 19075265 9834237 16966277 12018890 17869043 19035177 11161223 17217047 15748426 17712046 17107899 16823087 16331271 12712474 15336539 17649720 11468182 16330433 15213294 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
resveratrol |
21.92 | 16087638 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Thiophenes |
21.92 | 16140955 16140954 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
21.92 | 17301526 19075265 17506722 19642359 17361223 9834237 19225113 17339181 16891316 17649720 12679006 17368321 16935935 16823087 19029980 16331271 17712046 16766008 17294898 16788101 15748426 17107899 16140955 17217047 19035177 |
MESH:D015458 |
Leukemia, T-Cell |
|
arsenic trioxide |
9.05 | 16882451 |
MESH:D015458 |
Leukemia, T-Cell |
|
Curcumin |
9.05 | 16106398 |
MESH:D007972 |
Leukoplakia, Oral |
|
Fenretinide |
5.19 | 16707609 |
MESH:D020961 |
Lewy Body Disease |
|
Iron |
4.61 | 16563566 |
MESH:D056929 |
Liddle Syndrome |
|
Amiloride |
5.15 | 19344079 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Ethanol |
10.11 | 17676605 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Thalidomide |
10.11 | 10473037 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
10.11 | 9224671 |
MESH:D008103 |
Liver Cirrhosis |
|
Carbon Tetrachloride |
31.73 | 16239168 16943688 17174718 17157831 16221502 11903743 21278145 11408273 17334410 |
MESH:D008103 |
Liver Cirrhosis |
|
copolymer 1 |
31.73 | 17038628 |
MESH:D008103 |
Liver Cirrhosis |
|
Dietary Fats |
31.73 | 18296743 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
31.73 | 19638242 20032147 18665156 18407596 18522880 |
MESH:D008103 |
Liver Cirrhosis |
|
Ethanol |
31.73 | 15289165 |
MESH:D008103 |
Liver Cirrhosis |
|
Iron |
31.73 | 16640825 |
MESH:D008103 |
Liver Cirrhosis |
|
orlistat |
31.73 | 17404856 |
MESH:D008103 |
Liver Cirrhosis |
|
Phenobarbital |
31.73 | 21047994 |
MESH:D008103 |
Liver Cirrhosis |
|
Thalidomide |
31.73 | 16943688 17174718 |
MESH:D008104 |
Liver Cirrhosis, Alcoholic |
|
Ethanol |
4.26 | 18295389 |
MESH:D008105 |
Liver Cirrhosis, Biliary |
|
4,4'-diaminodiphenylmethane |
2.61 | 15034207 9327722 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide |
28.91 | 15876570 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Carbon Tetrachloride |
28.91 | 17640975 18277467 13678700 15959796 12546737 15893842 17525996 12609069 15876570 15650968 17761835 17721639 12445418 16097048 17708605 15931870 12958196 16011737 18210741 10355542 18156304 15362042 16248980 17565644 17557913 18481824 18418968 18420326 15338365 18429990 12898905 18317297 18412020 17631135 15730626 17944888 18251166 17922224 12445421 12632512 17805973 16192424 18395914 16136751 15673190 15057751 12667390 18705752 17714472 17698563 12632514 16116963 15818738 15925388 18376398 16015684 16638106 18339082 12741479 15123356 12586293 17766677 14716833 18166357 11481614 18054572 18187930 14748882 16027843 14716496 12666154 20821823 18395095 14512876 18472094 17976157 15996030 15052691 14620537 12649538 14724832 18205269 18263696 17900296 17869086 18006644 15370692 16033810 17481882 18279442 17823541 18472332 12389079 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Curcumin |
28.91 | 17355460 18006644 18705752 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Dexamethasone |
28.91 | 16718785 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Dimethylnitrosamine |
28.91 | 18095165 17640959 16627068 17201889 17465448 12918455 14709902 18371158 17348192 16270385 17036385 17198567 18364076 18210741 15864749 15591649 15942678 18567088 15492853 17203207 15067225 16603200 14568256 18239293 18672772 15798949 17432682 12925901 15081153 15383259 17666798 18637143 15763062 17196135 15479170 15733078 15298665 14726149 16042886 15161499 15099470 17724770 17719030 15086199 16009107 16544323 18237412 15366600 15571005 17534399 16570917 15577212 15138612 15842777 14659978 15744066 15723089 15339415 17881167 15369754 15793283 14643895 16169303 15504291 18629640 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
28.91 | 16439617 16595196 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
epigallocatechin gallate |
28.91 | 17481882 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
28.91 | 14716833 14659978 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Ethanol |
28.91 | 18166357 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Genistein |
28.91 | 17823541 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Poly I-C |
28.91 | 18166357 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Quercetin |
28.91 | 12741479 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
28.91 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Thalidomide |
28.91 | 15465738 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
28.91 | 18397230 16248980 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Vitamin E |
28.91 | 16169303 |
MESH:D008107 |
Liver Diseases |
|
Arsenic |
11.70 | 11134558 |
MESH:D008107 |
Liver Diseases |
|
Carbon Tetrachloride |
11.70 | 16246199 15720792 17285989 16964402 15830285 |
MESH:D008107 |
Liver Diseases |
|
Curcumin |
11.70 | 16956363 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
11.70 | 17034775 |
MESH:D008107 |
Liver Diseases |
|
Phenobarbital |
11.70 | 19363144 |
MESH:D008107 |
Liver Diseases |
|
polyphenols |
11.70 | 16698588 |
MESH:D008108 |
Liver Diseases, Alcoholic |
|
Ethanol |
8.78 | 17207112 17347304 |
MESH:D008108 |
Liver Diseases, Alcoholic |
|
Iron |
8.78 | 16737972 17207112 |
MESH:D017093 |
Liver Failure |
|
Carbon Tetrachloride |
3.35 | 15123358 |
MESH:D017114 |
Liver Failure, Acute |
|
Carbon Tetrachloride |
7.37 | 16899240 14706259 |
MESH:D017114 |
Liver Failure, Acute |
|
Dimethylnitrosamine |
7.37 | 17457977 |
MESH:D008113 |
Liver Neoplasms |
therapeutic |
|
| 18980244 |
MESH:D008113 |
Liver Neoplasms |
|
Arsenic |
43.42 | 16368122 |
MESH:D008113 |
Liver Neoplasms |
|
arsenic trioxide |
43.42 | 14682389 |
MESH:D008113 |
Liver Neoplasms |
|
Carbon Tetrachloride |
43.42 | 19294768 |
MESH:D008113 |
Liver Neoplasms |
|
dicyclanil |
43.42 | 20118626 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
43.42 | 19090486 19850985 19551842 20452335 19294768 15885732 20501860 19255062 15175105 20405173 18648771 10737359 18978307 20492335 19254457 20434301 20118626 16942905 18977376 19812893 2422723 19638242 20101389 19996281 19427195 19499222 21278145 18644402 19642983 18754104 20137499 21167192 12771043 21071580 21047994 12112319 19690152 19256749 19426721 9163691 19073162 20583210 19833225 2862719 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylstilbestrol |
43.42 | 15890375 16712894 |
MESH:D008113 |
Liver Neoplasms |
|
Dimethylnitrosamine |
43.42 | 15890375 3113478 |
MESH:D008113 |
Liver Neoplasms |
|
Fluorouracil |
43.42 | 17045692 16603448 18383874 15113037 |
MESH:D008113 |
Liver Neoplasms |
|
Iron |
43.42 | 20302851 16640825 |
MESH:D008113 |
Liver Neoplasms |
|
Mitomycin |
43.42 | 15113037 |
MESH:D008113 |
Liver Neoplasms |
|
Phenobarbital |
43.42 | 8742319 15975961 19812893 21047994 19482888 19073162 |
MESH:D008113 |
Liver Neoplasms |
|
Quercetin |
43.42 | 18980244 |
MESH:D008113 |
Liver Neoplasms |
|
resveratrol |
43.42 | 19073162 19812893 19321006 20405173 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
43.42 | 16712894 15276417 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
43.42 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
4,4'-diaminodiphenylmethane |
39.07 | 6587162 598648 3712494 1399818 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
arsenic trioxide |
39.07 | 20377131 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Ascorbic Acid |
39.07 | 18544905 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
beta Carotene |
39.07 | 17113696 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Carbon Tetrachloride |
39.07 | 15583823 12014681 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
39.07 | 17174075 9362446 16267830 17942915 2563599 17854601 19539802 18544905 19004024 21159647 19519916 18308698 19009564 18164116 19126423 18079962 3124819 18093689 18282651 18253720 16842330 18775883 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Dimethylnitrosamine |
39.07 | 6150874 15603536 1848544 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
39.07 | 17085340 16842330 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
kojic acid |
39.07 | 18544905 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Phenobarbital |
39.07 | 18308698 2563599 6150874 17172636 1399818 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Quercetin |
39.07 | 19519916 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
39.07 | 12151625 |
MESH:D008133 |
Long QT Syndrome |
|
arsenic trioxide |
2.69 | 15213294 |
MESH:D008171 |
Lung Diseases |
|
Acetylcysteine |
20.83 | 12815614 |
MESH:D008171 |
Lung Diseases |
|
Ascorbic Acid |
20.83 | 16863852 |
MESH:D008171 |
Lung Diseases |
|
Mustard Gas |
20.83 | 18702808 18161513 |
MESH:D008171 |
Lung Diseases |
|
Ozone |
20.83 | 19066396 8266340 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
20.83 | 19095001 |
MESH:D008171 |
Lung Diseases |
|
Vitamin E |
20.83 | 16863852 |
MESH:D055370 |
Lung Injury |
|
Ozone |
3.05 | 20417186 |
MESH:D008175 |
Lung Neoplasms |
|
alitretinoin |
42.53 | 16413115 |
MESH:D008175 |
Lung Neoplasms |
|
Arsenic |
42.53 | 17976673 17306315 19168569 |
MESH:D008175 |
Lung Neoplasms |
|
arsenic trioxide |
42.53 | 11798837 19825857 |
MESH:D008175 |
Lung Neoplasms |
|
Ascorbic Acid |
42.53 | 16401635 |
MESH:D008175 |
Lung Neoplasms |
|
beta Carotene |
42.53 | 16401635 |
MESH:D008175 |
Lung Neoplasms |
|
Cisplatin |
42.53 | 11798837 17225452 6189445 |
MESH:D008175 |
Lung Neoplasms |
|
Curcumin |
42.53 | 19359593 18462866 16243823 |
MESH:D008175 |
Lung Neoplasms |
|
Dexamethasone |
42.53 | 11195469 15824018 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
42.53 | 6695378 20970405 20512841 21163286 |
MESH:D008175 |
Lung Neoplasms |
|
Dimethylnitrosamine |
42.53 | 16061637 11884234 19555203 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
42.53 | 6189445 17418594 |
MESH:D008175 |
Lung Neoplasms |
|
Fluorouracil |
42.53 | 15246190 |
MESH:D008175 |
Lung Neoplasms |
|
Iron |
42.53 | 16640825 |
MESH:D008175 |
Lung Neoplasms |
|
Mustard Gas |
42.53 | 8781369 3148597 |
MESH:D008175 |
Lung Neoplasms |
|
Ozone |
42.53 | 8597069 7614698 |
MESH:D008175 |
Lung Neoplasms |
|
Quercetin |
42.53 | 16280456 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
42.53 | 15276417 19931552 17077188 17306315 16712894 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
42.53 | 19555203 11884234 |
MESH:D008175 |
Lung Neoplasms |
|
Tobacco Smoke Pollution |
42.53 | 12111688 11091918 16288123 3440675 |
MESH:D008175 |
Lung Neoplasms |
|
Vitamin E |
42.53 | 11062179 |
MESH:D008175 |
Lung Neoplasms |
|
Zidovudine |
42.53 | 18800350 |
MESH:D008178 |
Lupus Erythematosus, Cutaneous |
|
Fluorouracil |
3.95 | 15086387 |
MESH:D008181 |
Lupus Nephritis |
|
Diethylstilbestrol |
4.31 | 15166399 |
MESH:D008207 |
Lymphatic Metastasis |
|
orlistat |
5.08 | 18770866 20805790 |
MESH:D008223 |
Lymphoma |
|
bortezomib |
16.70 | 16098063 |
MESH:D008223 |
Lymphoma |
|
Curcumin |
16.70 | 18462866 |
MESH:D008223 |
Lymphoma |
|
decitabine |
16.70 | 19470736 |
MESH:D008223 |
Lymphoma |
|
Diethylstilbestrol |
16.70 | 15700306 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
16.70 | 16098063 |
MESH:D016393 |
Lymphoma, B-Cell |
|
bortezomib |
12.80 | 16675587 |
MESH:D016393 |
Lymphoma, B-Cell |
|
resveratrol |
12.80 | 17088997 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Sodium Selenite |
12.80 | 14737004 |
MESH:D017728 |
Lymphoma, Large-Cell, Anaplastic |
|
17-(allylamino)-17-demethoxygeldanamycin |
5.77 | 17157164 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
6.53 | 17654614 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
resveratrol |
6.53 | 14749477 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Curcumin |
8.85 | 16173963 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
8.85 | 15621674 |
MESH:D016410 |
Lymphoma, T-Cell, Cutaneous |
|
vorinostat |
4.86 | 20479100 |
MESH:D008268 |
Macular Degeneration |
|
Iron |
3.45 | 16640825 |
MESH:D052801 |
Male Urogenital Diseases |
|
Diethylstilbestrol |
4.66 | 16002989 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
resveratrol |
3.42 | 15688416 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
23.12 | 15458769 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
23.12 | 17203775 16891317 11408345 11807958 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Fenretinide |
23.12 | 10697514 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Genistein |
23.12 | 12929590 14578162 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Progesterone |
23.12 | 11408345 17203775 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
resveratrol |
23.12 | 11606380 8985016 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Selenium |
23.12 | 15318939 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
selenomethylselenocysteine |
23.12 | 15318939 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
3.63 | 19453300 |
MESH:D008527 |
Medulloblastoma |
|
bortezomib |
5.48 | 19213072 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
5.48 | 17453147 |
MESH:D008545 |
Melanoma |
|
Cisplatin |
25.23 | 12393984 15577323 16432458 18332650 18176117 11135225 16809738 17761969 12374674 16248763 12883367 18505091 17023156 |
MESH:D008545 |
Melanoma |
|
Curcumin |
25.23 | 17885582 18462866 |
MESH:D008545 |
Melanoma |
|
Dacarbazine |
25.23 | 12883367 11254118 11712820 17334785 16966688 12393984 12202904 12640292 17562445 12439608 16225601 17119449 10623706 15522559 11746506 15577323 12417787 16098027 17239242 18089842 12535206 15020614 18281670 16034308 16273263 18505091 18332650 18176117 18445842 12025231 16760174 17508024 17761969 12556972 11135225 17623835 16508601 16248763 16928243 17023156 15577320 17576460 17709802 15917704 17973783 16809738 16939954 15176220 |
MESH:D008545 |
Melanoma |
|
decitabine |
25.23 | 17785578 16505122 |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
25.23 | 16827129 |
MESH:D008545 |
Melanoma |
|
epigallocatechin gallate |
25.23 | 17992120 11746506 |
MESH:D008545 |
Melanoma |
|
Fenretinide |
25.23 | 16270382 |
MESH:D008545 |
Melanoma |
|
orlistat |
25.23 | 18770866 20805790 |
MESH:D008545 |
Melanoma |
|
resveratrol |
25.23 | 17992120 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
25.23 | 19082730 16487513 |
MESH:D008545 |
Melanoma |
|
Thalidomide |
25.23 | 12829675 17089043 16098027 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
25.23 | 16752155 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Cisplatin |
9.38 | 15990972 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Dacarbazine |
9.38 | 15990972 |
MESH:D008569 |
Memory Disorders |
|
Curcumin |
7.11 | 17263510 |
MESH:D008569 |
Memory Disorders |
|
Ethanol |
7.11 | 18411066 15451040 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
3.60 | 16940565 |
MESH:D008654 |
Mesothelioma |
|
Cisplatin |
7.76 | 17638057 |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
7.76 | 17638057 |
MESH:D008654 |
Mesothelioma |
|
Selenium |
7.76 | 15107826 |
MESH:D008659 |
Metabolic Diseases |
|
resveratrol |
3.61 | 17112576 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
3.93 | 16801185 |
MESH:D008679 |
Metaplasia |
|
Ozone |
4.25 | 10496685 |
MESH:D048629 |
Micronuclei, Chromosome-Defective |
|
Zidovudine |
4.98 | 17358032 |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
3.73 | 15792986 |
MESH:D009062 |
Mouth Neoplasms |
|
Fenretinide |
10.71 | 16274795 |
MESH:D009062 |
Mouth Neoplasms |
|
Fluorouracil |
10.71 | 16757204 18986760 |
MESH:D009062 |
Mouth Neoplasms |
|
Tobacco Smoke Pollution |
10.71 | 15006635 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
9.64 | 17415656 |
MESH:D052016 |
Mucositis |
|
irinotecan |
9.64 | 17159606 |
MESH:D009101 |
Multiple Myeloma |
|
arsenic trioxide |
24.29 | 11468182 15949261 19549372 14977855 19417148 |
MESH:D009101 |
Multiple Myeloma |
|
bortezomib |
24.29 | 19372569 19112201 19112817 |
MESH:D009101 |
Multiple Myeloma |
|
Curcumin |
24.29 | 19372569 |
MESH:D009101 |
Multiple Myeloma |
|
decitabine |
24.29 | 18172295 |
MESH:D009101 |
Multiple Myeloma |
|
Dexamethasone |
24.29 | 15867202 15744524 16118317 |
MESH:D009101 |
Multiple Myeloma |
|
resveratrol |
24.29 | 17935668 16267019 14749477 17164350 17049120 16490592 |
MESH:D009101 |
Multiple Myeloma |
|
Thalidomide |
24.29 | 15744524 17168659 15867202 19112201 19372569 15939924 19112817 15920492 15741222 16445831 |
MESH:D020528 |
Multiple Sclerosis, Chronic Progressive |
|
Iron |
4.82 | 17086897 |
MESH:D009134 |
Muscular Atrophy, Spinal |
|
Curcumin |
16.33 | 17962980 |
MESH:D009134 |
Muscular Atrophy, Spinal |
|
epigallocatechin gallate |
16.33 | 17962980 |
MESH:D009134 |
Muscular Atrophy, Spinal |
|
resveratrol |
16.33 | 17962980 |
MESH:D009135 |
Muscular Diseases |
|
orlistat |
4.63 | 18430571 |
MESH:D009164 |
Mycobacterium Infections |
|
orlistat |
4.65 | 21442799 |
MESH:D009181 |
Mycoses |
|
Iron |
4.62 | 16640825 |
MESH:D009182 |
Mycosis Fungoides |
|
arsenic trioxide |
3.82 | 18349030 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
arsenic trioxide |
17.24 | 16105982 16882451 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
decitabine |
17.24 | 18608210 16882708 19010910 19157545 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Dexamethasone |
17.24 | 9809623 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Thalidomide |
17.24 | 18720364 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
17.24 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
9.95 | 19429709 15857846 |
MESH:D009203 |
Myocardial Infarction |
|
Genistein |
9.95 | 17141266 |
MESH:D009203 |
Myocardial Infarction |
|
Quercetin |
9.95 | 19595682 |
MESH:D009203 |
Myocardial Infarction |
|
resveratrol |
9.95 | 16317513 17125593 16525036 17188708 16456233 17015251 |
MESH:D017202 |
Myocardial Ischemia |
|
Arsenic |
16.19 | 15371236 |
MESH:D017202 |
Myocardial Ischemia |
|
Iron |
16.19 | 16604332 |
MESH:D017202 |
Myocardial Ischemia |
|
resveratrol |
16.19 | 17015251 17125593 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
16.19 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
14.83 | 16810080 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Genistein |
14.83 | 17141266 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Iron |
14.83 | 16604332 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Quercetin |
14.83 | 19207477 |
MESH:D009205 |
Myocarditis |
|
resveratrol |
3.92 | 17322642 |
MESH:D020191 |
Myoclonic Epilepsies, Progressive |
|
Phenobarbital |
3.64 | 17484760 |
MESH:D009325 |
Nausea |
|
vorinostat |
4.67 | 20479100 |
MESH:D009336 |
Necrosis |
|
Trinitrotoluene |
3.93 | 18551238 |
MESH:D009361 |
Neoplasm Invasiveness |
|
Amiloride |
12.82 | 14644129 |
MESH:D009361 |
Neoplasm Invasiveness |
|
arsenic trioxide |
12.82 | 16624393 |
MESH:D009361 |
Neoplasm Invasiveness |
|
Curcumin |
12.82 | 18495463 |
MESH:D009362 |
Neoplasm Metastasis |
|
4,4'-diaminodiphenylmethane |
13.36 | 3581430 |
MESH:D009362 |
Neoplasm Metastasis |
|
Acetylcysteine |
13.36 | 14720322 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
13.36 | 9029167 3581430 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
13.36 | 18259882 |
MESH:D009362 |
Neoplasm Metastasis |
|
irinotecan |
13.36 | 18259882 |
MESH:D009369 |
Neoplasms |
|
alitretinoin |
30.07 | 16946489 |
MESH:D009369 |
Neoplasms |
|
beta Carotene |
30.07 | 17051425 |
MESH:D009369 |
Neoplasms |
|
Cisplatin |
30.07 | 16773208 |
MESH:D009369 |
Neoplasms |
|
decitabine |
30.07 | 17925555 19116145 19470736 |
MESH:D009369 |
Neoplasms |
|
Diethylstilbestrol |
30.07 | 15313581 |
MESH:D009369 |
Neoplasms |
|
Fenretinide |
30.07 | 15958647 17353921 |
MESH:D009369 |
Neoplasms |
|
Fluorouracil |
30.07 | 18600527 18239605 16928823 |
MESH:D009369 |
Neoplasms |
|
orlistat |
30.07 | 18710210 |
MESH:D009369 |
Neoplasms |
|
Quercetin |
30.07 | 15185748 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
30.07 | 11559025 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
30.07 | 16594593 16946489 |
MESH:D009374 |
Neoplasms, Experimental |
|
orlistat |
10.80 | 19381703 |
MESH:D009374 |
Neoplasms, Experimental |
|
resveratrol |
10.80 | 8985016 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
10.80 | 20056578 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Curcumin |
3.69 | 12497104 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
7.73 | 17289903 |
MESH:D009389 |
Neovascularization, Pathologic |
|
orlistat |
7.73 | 17012255 |
MESH:D009395 |
Nephritis, Interstitial |
|
Cisplatin |
3.65 | 15464296 |
MESH:D009397 |
Nephrocalcinosis |
|
Furosemide |
5.02 | 15086907 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
3.95 | 16636307 16899518 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
3.59 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
11.62 | 19348381 18481113 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
11.62 | 16889571 15640375 |
MESH:D009404 |
Nephrotic Syndrome |
|
Iron |
11.62 | 17178036 |
MESH:D009421 |
Nervous System Malformations |
|
Diethylstilbestrol |
28.05 | 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
28.05 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Genistein |
28.05 | 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
28.05 | 14600291 |
MESH:D009421 |
Nervous System Malformations |
|
Thalidomide |
28.05 | 16859833 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
28.05 | 9125849 |
MESH:D009423 |
Nervous System Neoplasms |
|
Curcumin |
4.78 | 18462866 |
MESH:D009436 |
Neural Tube Defects |
|
4,4'-diaminodiphenylmethane |
20.60 | 6679447 |
MESH:D009436 |
Neural Tube Defects |
|
Acetylcysteine |
20.60 | 19446573 |
MESH:D009436 |
Neural Tube Defects |
|
Arsenic |
20.60 | 16620997 |
MESH:D009436 |
Neural Tube Defects |
|
arsenic trioxide |
20.60 | 10525206 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
20.60 | 12854658 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
20.60 | 9142499 |
MESH:D009447 |
Neuroblastoma |
|
Cisplatin |
8.54 | 8761367 |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
8.54 | 15555623 |
MESH:D009447 |
Neuroblastoma |
|
irinotecan |
8.54 | 8761367 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
10.16 | 20387270 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Iron |
10.16 | 16604332 17296847 |
MESH:D019636 |
Neurodegenerative Diseases |
|
resveratrol |
10.16 | 17652729 |
MESH:D017599 |
Neuroectodermal Tumors |
|
Cisplatin |
8.69 | 8761367 |
MESH:D017599 |
Neuroectodermal Tumors |
|
irinotecan |
8.69 | 8761367 |
MESH:D020078 |
Neurogenic Inflammation |
|
Arsenic |
13.32 | 17056641 |
MESH:D020078 |
Neurogenic Inflammation |
|
Quercetin |
13.32 | 17929310 |
MESH:D020078 |
Neurogenic Inflammation |
|
resveratrol |
13.32 | 17929310 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
4.26 | 20387270 |
MESH:D009472 |
Neuronal Ceroid-Lipofuscinoses |
|
Fenretinide |
4.84 | 16303764 |
MESH:D020258 |
Neurotoxicity Syndromes |
|
Fluorouracil |
2.82 | 16436463 |
MESH:D009503 |
Neutropenia |
|
Mustard Gas |
3.20 | 16761898 7688884 |
MESH:D052556 |
Niemann-Pick Disease, Type C |
|
Cholesterol |
4.88 | 9802331 20557099 |
MESH:D053206 |
Nocturnal Enuresis |
|
Furosemide |
5.02 | 17945291 |
MESH:C541083 |
Non-alcoholic Fatty Liver Disease |
|
orlistat |
4.79 | 17404856 |
MESH:D009765 |
Obesity |
|
Ascorbic Acid |
8.21 | 17217161 |
MESH:D009765 |
Obesity |
|
Curcumin |
8.21 | 19297423 |
MESH:D009765 |
Obesity |
|
Dietary Fats |
8.21 | 17217161 19632207 16723640 21332399 18457598 20132043 18674790 11836018 20518802 |
MESH:D009765 |
Obesity |
|
orlistat |
8.21 | 19207292 16938137 18773755 19461584 20065556 20599501 21438711 21442799 20540997 20518802 19046740 20002075 |
MESH:D009784 |
Occupational Diseases |
|
4,4'-diaminodiphenylmethane |
6.75 | 4026338 6482804 |
MESH:D009784 |
Occupational Diseases |
|
Trinitrotoluene |
6.75 | 17852074 14694615 12819281 |
MESH:D009902 |
Optic Neuritis |
|
4,4'-diaminodiphenylmethane |
4.16 | 3988306 |
MESH:D010003 |
Osteoarthritis |
|
Iron |
3.40 | 16640825 |
MESH:D010018 |
Osteomalacia |
|
Phenobarbital |
3.53 | 17016548 |
MESH:D010024 |
Osteoporosis |
|
Curcumin |
12.26 | 18719352 |
MESH:D010024 |
Osteoporosis |
|
Genistein |
12.26 | 19401787 |
MESH:D010024 |
Osteoporosis |
|
Iron |
12.26 | 16640825 16648989 |
MESH:D010024 |
Osteoporosis |
|
Vitamin D |
12.26 | 17882678 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Genistein |
12.40 | 16169203 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Quercetin |
12.40 | 19495926 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
resveratrol |
12.40 | 17513867 |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
3.42 | 15930896 |
MESH:D010051 |
Ovarian Neoplasms |
|
Arsenic |
43.42 | 17306315 |
MESH:D010051 |
Ovarian Neoplasms |
|
arsenic trioxide |
43.42 | 16624393 12452020 19769630 |
MESH:D010051 |
Ovarian Neoplasms |
|
Cisplatin |
43.42 | 6897625 15464296 17225452 19769630 |
MESH:D010051 |
Ovarian Neoplasms |
|
Curcumin |
43.42 | 19020741 18462866 |
MESH:D010051 |
Ovarian Neoplasms |
|
decitabine |
43.42 | 19259094 19331143 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
43.42 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Fenretinide |
43.42 | 16133793 |
MESH:D010051 |
Ovarian Neoplasms |
|
Genistein |
43.42 | 19005980 |
MESH:D010051 |
Ovarian Neoplasms |
|
Luteolin |
43.42 | 19005980 |
MESH:D010051 |
Ovarian Neoplasms |
|
Progesterone |
43.42 | 16525653 17393432 |
MESH:D010051 |
Ovarian Neoplasms |
|
Quercetin |
43.42 | 19005980 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
43.42 | 15276417 17306315 |
MESH:D010051 |
Ovarian Neoplasms |
|
Thalidomide |
43.42 | 16288038 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
43.42 | 16936753 |
MESH:D010146 |
Pain |
|
Tretinoin |
2.25 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
arsenic trioxide |
42.12 | 15580305 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Cisplatin |
42.12 | 19003803 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Curcumin |
42.12 | 17440100 19401701 19196508 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Dacarbazine |
42.12 | 11583197 |
MESH:D010190 |
Pancreatic Neoplasms |
|
decitabine |
42.12 | 19294695 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
42.12 | 16540662 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Ethanol |
42.12 | 12384795 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Fenretinide |
42.12 | 15580305 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Fluorouracil |
42.12 | 19003803 16929163 16500647 15113037 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Mitomycin |
42.12 | 15113037 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Phenobarbital |
42.12 | 16965848 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Quercetin |
42.12 | 16965848 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
42.12 | 15976015 |
MESH:D010195 |
Pancreatitis |
|
orlistat |
4.09 | 16938137 20065556 |
MESH:D010212 |
Papilloma |
|
4,4'-diaminodiphenylmethane |
6.77 | 7296757 |
MESH:D010212 |
Papilloma |
|
Iron |
6.77 | 12065085 |
MESH:D010235 |
Paraganglioma |
|
arsenic trioxide |
3.38 | 19927285 |
MESH:D020447 |
Parasomnias |
|
Iron |
5.16 | 17352947 |
MESH:D010291 |
Paresis |
|
Thalidomide |
5.45 | 9200351 |
MESH:D010300 |
Parkinson Disease |
|
Iron |
2.95 | 16640825 16563566 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
3.39 | 12520081 |
MESH:D010409 |
Penile Diseases |
|
Antimony |
4.92 | 9643325 |
MESH:D010493 |
Pericarditis |
|
Antimony |
5.27 | 20465667 |
MESH:D010523 |
Peripheral Nervous System Diseases |
|
Arsenic |
7.42 | 16093927 |
MESH:D010523 |
Peripheral Nervous System Diseases |
|
Cisplatin |
7.42 | 15464296 |
MESH:D016491 |
Peripheral Vascular Diseases |
|
Arsenic |
10.31 | 16905509 6392382 15371236 |
MESH:D016491 |
Peripheral Vascular Diseases |
|
Cadmium |
10.31 | 15687053 |
MESH:D010538 |
Peritonitis |
|
Isoflurane |
7.83 | 17414419 |
MESH:D010538 |
Peritonitis |
|
Ozone |
7.83 | 16369182 |
MESH:D010787 |
Photosensitivity Disorders |
|
4,4'-diaminodiphenylmethane |
3.62 | 6228378 |
MESH:D003557 |
Phyllodes Tumor |
|
Dacarbazine |
11.53 | 17983394 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
11.53 | 17983394 |
MESH:D010900 |
Pituitary Diseases |
|
Diethylstilbestrol |
11.23 | 14722030 |
MESH:D010900 |
Pituitary Diseases |
|
Iron |
11.23 | 16604332 |
MESH:D010911 |
Pituitary Neoplasms |
|
Diethylstilbestrol |
3.85 | 15687265 16977796 |
MESH:D010954 |
Plasmacytoma |
|
Selenium |
4.03 | 15087411 |
MESH:D010997 |
Pleural Neoplasms |
|
Cisplatin |
11.10 | 17638057 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
11.10 | 17638057 |
MESH:D011014 |
Pneumonia |
|
Ozone |
3.56 | 18929643 18007984 18381685 |
MESH:D011041 |
Poisoning |
|
Iron |
6.43 | 16604332 |
MESH:D011041 |
Poisoning |
|
Mustard Gas |
6.43 | 15727166 |
MESH:D011085 |
Polycystic Ovary Syndrome |
|
orlistat |
4.53 | 17201808 |
MESH:D011141 |
Polyuria |
|
Furosemide |
4.81 | 17945291 |
MESH:D017499 |
Porokeratosis |
|
alitretinoin |
5.15 | 16144296 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Iron |
8.36 | 16640825 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
8.36 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
15.96 | 12371664 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
15.96 | 2563599 |
MESH:D011230 |
Precancerous Conditions |
|
Phenobarbital |
15.96 | 2563599 |
MESH:D011230 |
Precancerous Conditions |
|
Quercetin |
15.96 | 19056647 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Cytarabine |
9.54 | 21297632 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Dexamethasone |
9.54 | 21297632 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Thalidomide |
9.54 | 17031469 |
MESH:D011225 |
Pre-Eclampsia |
|
Iron |
3.75 | 16640825 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Diethylstilbestrol |
11.51 | 17184923 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
resveratrol |
11.51 | 16679765 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
11.51 | 11399792 11118676 11896295 11222880 |
MESH:D055728 |
Primary Myelofibrosis |
|
decitabine |
3.91 | 17616702 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
3.12 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
therapeutic |
|
| 17636462 17718901 16368536 |
MESH:D011471 |
Prostatic Neoplasms |
|
Arsenic |
10.48 | 16140617 |
MESH:D011471 |
Prostatic Neoplasms |
|
arsenic trioxide |
10.48 | 19131511 |
MESH:D011471 |
Prostatic Neoplasms |
|
Cadmium |
10.48 | 17075824 |
MESH:D011471 |
Prostatic Neoplasms |
|
Curcumin |
10.48 | 18769126 18156803 11398177 18226269 10851300 15129424 12497104 |
MESH:D011471 |
Prostatic Neoplasms |
|
Diethylstilbestrol |
10.48 | 15846301 15046698 17136230 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
10.48 | 16888761 15897917 15749863 18437689 16729912 16868541 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
10.48 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Fenretinide |
10.48 | 17024972 |
MESH:D011471 |
Prostatic Neoplasms |
|
Fluorouracil |
10.48 | 18626508 19082440 |
MESH:D011471 |
Prostatic Neoplasms |
|
Genistein |
10.48 | 15256057 16925846 15378649 |
MESH:D011471 |
Prostatic Neoplasms |
|
Nordihydroguaiaretic Acid |
10.48 | 18491370 |
MESH:D011471 |
Prostatic Neoplasms |
|
panduratin A |
10.48 | 16497706 |
MESH:D011471 |
Prostatic Neoplasms |
|
Quercetin |
10.48 | 14715546 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
resveratrol |
10.48 | 17675339 17804756 16731767 17718901 15767336 17636462 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
10.48 | 16039940 |
MESH:D011471 |
Prostatic Neoplasms |
|
Sodium Selenite |
10.48 | 18760546 |
MESH:D011471 |
Prostatic Neoplasms |
|
Thalidomide |
10.48 | 16729912 |
MESH:D011471 |
Prostatic Neoplasms |
|
Vitamin E |
10.48 | 15084515 |
MESH:D011471 |
Prostatic Neoplasms |
|
vorinostat |
10.48 | 17218635 |
MESH:D011507 |
Proteinuria |
|
Arsenic |
6.70 | 21343184 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
6.70 | 16636307 |
MESH:D011528 |
Protozoan Infections |
|
Iron |
5.16 | 16640825 |
MESH:D011536 |
Prurigo |
|
Thalidomide |
5.45 | 12755975 |
MESH:D011537 |
Pruritus |
|
Mustard Gas |
3.27 | 18058305 |
MESH:D019310 |
Pseudolymphoma |
|
Phenobarbital |
3.64 | 12752131 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
1.86 | 16882103 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
3.95 | 16723453 |
MESH:D011656 |
Pulmonary Emphysema |
|
Curcumin |
3.78 | 19168576 |
MESH:D011657 |
Pulmonary Eosinophilia |
|
Ascorbic Acid |
4.48 | 14606601 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Mustard Gas |
2.54 | 17894541 17266442 17720292 17620002 10334151 |
MESH:D012004 |
Rectal Neoplasms |
|
Fluorouracil |
3.28 | 18286688 18722050 15538739 16160472 |
MESH:D012035 |
Refsum Disease |
|
orlistat |
5.23 | 20871815 |
MESH:D051437 |
Renal Insufficiency |
|
Cisplatin |
7.67 | 15464296 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
7.67 | 17922066 |
MESH:D051436 |
Renal Insufficiency, Chronic |
|
resveratrol |
4.73 | 16325855 |
MESH:D015427 |
Reperfusion Injury |
|
Furosemide |
5.48 | 16526316 |
MESH:D015427 |
Reperfusion Injury |
|
resveratrol |
5.48 | 17520802 16317513 16314181 17058453 15827377 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Acetylcysteine |
15.33 | 12210543 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Curcumin |
15.33 | 10666014 18379247 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Dexamethasone |
15.33 | 18379247 11700416 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Furosemide |
15.33 | 15912074 12394941 16096441 |
MESH:D012135 |
Respiratory Sounds |
|
Tobacco Smoke Pollution |
3.82 | 18410779 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.03 | 18990726 |
MESH:D012148 |
Restless Legs Syndrome |
|
Iron |
3.88 | 16930377 |
MESH:D012162 |
Retinal Degeneration |
|
4,4'-diaminodiphenylmethane |
6.90 | 3692021 |
MESH:D012162 |
Retinal Degeneration |
|
Fenretinide |
6.90 | 16303925 |
MESH:D012174 |
Retinitis Pigmentosa |
|
Ascorbic Acid |
3.00 | 16849425 |
MESH:D012208 |
Rhabdomyosarcoma |
|
decitabine |
8.35 | 19155313 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
8.35 | 16116481 16283617 |
MESH:D012468 |
Salivary Gland Neoplasms |
|
Progesterone |
2.48 | 18045962 |
MESH:D012509 |
Sarcoma |
|
Curcumin |
11.68 | 18462866 |
MESH:D012509 |
Sarcoma |
|
Dacarbazine |
11.68 | 18313854 17898927 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
11.68 | 15625365 15675481 16767912 18313854 17710206 17203757 |
MESH:D012512 |
Sarcoma, Ewing's |
|
arsenic trioxide |
12.68 | 16646077 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Cisplatin |
12.68 | 14601052 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
12.68 | 14601052 16326096 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
3.95 | 17846226 |
MESH:D012554 |
Schistosomiasis japonica |
|
Quercetin |
4.69 | 16862918 |
MESH:D019873 |
Schnitzler Syndrome |
|
Thalidomide |
5.10 | 16096327 |
MESH:D012640 |
Seizures |
|
Ethanol |
6.48 | 9754883 |
MESH:D012640 |
Seizures |
|
Phenobarbital |
6.48 | 3137016 4039156 16876388 11442880 |
MESH:D012640 |
Seizures |
|
Trinitrotoluene |
6.48 | 18551238 |
MESH:D003294 |
Seizures, Febrile |
|
Phenobarbital |
3.98 | 6407741 |
MESH:D018805 |
Sepsis |
|
Curcumin |
7.45 | 18389075 |
MESH:D018805 |
Sepsis |
|
Isoflurane |
7.45 | 17414419 |
MESH:D012871 |
Skin Diseases |
|
Arsenic |
8.74 | 16759981 18709164 6392382 16353154 16702368 17050553 19834688 17938729 15952646 17453740 17548696 |
MESH:D012871 |
Skin Diseases |
|
Ascorbic Acid |
8.74 | 18709164 |
MESH:D012871 |
Skin Diseases |
|
Mustard Gas |
8.74 | 15451306 12880345 16961503 |
MESH:D012871 |
Skin Diseases |
|
Vitamin E |
8.74 | 18709164 |
MESH:D012878 |
Skin Neoplasms |
|
Arsenic |
35.65 | 17029826 17050553 17976673 15504454 16251483 19538983 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
35.65 | 15692506 |
MESH:D012878 |
Skin Neoplasms |
|
Fenretinide |
35.65 | 16467112 |
MESH:D012878 |
Skin Neoplasms |
|
Iron |
35.65 | 12065085 |
MESH:D012878 |
Skin Neoplasms |
|
Okadaic Acid |
35.65 | 12628509 |
MESH:D012878 |
Skin Neoplasms |
|
resveratrol |
35.65 | 15837718 8985016 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
35.65 | 19524636 18572023 |
MESH:D012878 |
Skin Neoplasms |
|
tert-Butylhydroperoxide |
35.65 | 8532709 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
35.65 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Tobacco Smoke Pollution |
35.65 | 18590791 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
35.65 | 16467112 |
MESH:D055752 |
Small Cell Lung Carcinoma |
|
Cisplatin |
4.49 | 15464296 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
3.75 | 17203757 16767912 15625365 |
MESH:D013088 |
Spermatocele |
|
Diethylstilbestrol |
3.86 | 16002989 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Progesterone |
3.45 | 16503802 15862959 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.11 | 12854658 |
MESH:D013158 |
Splenic Diseases |
|
Dimethylnitrosamine |
4.42 | 12587719 |
MESH:D013163 |
Splenomegaly |
|
Trinitrotoluene |
4.38 | 15817613 |
MESH:D013272 |
Stomach Diseases |
|
beta Carotene |
7.85 | 17638125 |
MESH:D013272 |
Stomach Diseases |
|
Dexamethasone |
7.85 | 15472012 |
MESH:D013274 |
Stomach Neoplasms |
|
arsenic trioxide |
18.51 | 17007042 |
MESH:D013274 |
Stomach Neoplasms |
|
Cisplatin |
18.51 | 17522103 15958060 18396642 |
MESH:D013274 |
Stomach Neoplasms |
|
decitabine |
18.51 | 19037991 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
18.51 | 18456281 |
MESH:D013274 |
Stomach Neoplasms |
|
Dimethylnitrosamine |
18.51 | 16033868 |
MESH:D013274 |
Stomach Neoplasms |
|
Ethanol |
18.51 | 18456281 |
MESH:D013274 |
Stomach Neoplasms |
|
Fluorouracil |
18.51 | 18396642 19084572 18567086 19015929 17172411 16424979 16951190 17498489 15786421 17522103 |
MESH:D013274 |
Stomach Neoplasms |
|
Furosemide |
18.51 | 17052386 |
MESH:D013274 |
Stomach Neoplasms |
|
irinotecan |
18.51 | 15723263 |
MESH:D013274 |
Stomach Neoplasms |
|
orlistat |
18.51 | 19381703 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
18.51 | 17261132 |
MESH:D013274 |
Stomach Neoplasms |
|
Zidovudine |
18.51 | 17696246 |
MESH:D013276 |
Stomach Ulcer |
|
Acetylcysteine |
22.46 | 17918041 |
MESH:D013276 |
Stomach Ulcer |
|
Ascorbic Acid |
22.46 | 18726076 |
MESH:D013276 |
Stomach Ulcer |
|
beta Carotene |
22.46 | 12500499 |
MESH:D013276 |
Stomach Ulcer |
|
Curcumin |
22.46 | 16631530 19188055 |
MESH:D013276 |
Stomach Ulcer |
|
Dexamethasone |
22.46 | 15138204 |
MESH:D013276 |
Stomach Ulcer |
|
Ethanol |
22.46 | 17189318 16755016 9211565 11906479 9562338 17918041 |
MESH:D013276 |
Stomach Ulcer |
|
Thalidomide |
22.46 | 15138204 |
MESH:D020521 |
Stroke |
|
Ascorbic Acid |
6.59 | 16517955 16403987 |
MESH:D020521 |
Stroke |
|
Vitamin E |
6.59 | 16517955 |
OMIM:601367 |
STROKE, ISCHEMIC |
|
resveratrol |
3.73 | 16321402 |
MESH:D013375 |
Substance Withdrawal Syndrome |
|
Ethanol |
3.51 | 9754883 |
MESH:D013398 |
Sudden Infant Death |
|
Iron |
4.61 | 16640825 |
MESH:D013705 |
Temporomandibular Joint Disorders |
|
polyphenols |
4.40 | 17997062 |
MESH:D013736 |
Testicular Neoplasms |
|
Cisplatin |
3.85 | 15464296 17225452 |
MESH:D013921 |
Thrombocytopenia |
|
vorinostat |
4.23 | 20479100 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.05 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
4,4'-diaminodiphenylmethane |
27.95 | 1399818 3712494 6587162 7505956 6582329 |
MESH:D013964 |
Thyroid Neoplasms |
|
arsenic trioxide |
27.95 | 19014326 |
MESH:D013964 |
Thyroid Neoplasms |
|
Dacarbazine |
27.95 | 11815960 15634649 |
MESH:D013964 |
Thyroid Neoplasms |
|
decitabine |
27.95 | 17967635 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
27.95 | 7505956 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
27.95 | 17909728 16010429 |
MESH:D013964 |
Thyroid Neoplasms |
|
Phenobarbital |
27.95 | 1399818 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
27.95 | 16026305 17045167 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
3.83 | 19048282 |
MESH:D014062 |
Tongue Neoplasms |
|
Fluorouracil |
12.29 | 16280240 |
MESH:D014062 |
Tongue Neoplasms |
|
resveratrol |
12.29 | 16227395 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
12.29 | 16051514 |
MESH:D016171 |
Torsades de Pointes |
|
arsenic trioxide |
3.13 | 15213294 |
MESH:D014352 |
Trypanosomiasis |
|
Antimony |
5.08 | 15220340 |
MESH:D014376 |
Tuberculosis |
|
Iron |
6.22 | 16597321 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
6.22 | 16040207 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
4,4'-diaminodiphenylmethane |
35.93 | 8074119 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Arsenic |
35.93 | 19322015 19429237 11144890 18640142 17306315 15987713 17976673 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
arsenic trioxide |
35.93 | 12973940 20435036 12845720 11780464 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Cisplatin |
35.93 | 15464296 17225452 12973940 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Curcumin |
35.93 | 18593936 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
decitabine |
35.93 | 19087683 17616700 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Diethylstilbestrol |
35.93 | 17306315 16712894 16452187 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
35.93 | 17653716 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Fenretinide |
35.93 | 16720286 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Quercetin |
35.93 | 16720314 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
35.93 | 11723127 16452187 16712894 17306315 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tobacco Smoke Pollution |
35.93 | 12846360 |
MESH:D014565 |
Urogenital Neoplasms |
|
Curcumin |
4.42 | 18462866 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Cisplatin |
33.14 | 16803524 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Diethylstilbestrol |
33.14 | 16175088 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Fenretinide |
33.14 | 16154183 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Fluorouracil |
33.14 | 16803524 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
resveratrol |
33.14 | 17473185 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
33.14 | 11813266 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
33.14 | 16129372 |
MESH:D014591 |
Uterine Diseases |
|
Diethylstilbestrol |
4.32 | 14652134 |
MESH:D014594 |
Uterine Neoplasms |
|
Diethylstilbestrol |
11.66 | 16690809 15809267 |
MESH:D014594 |
Uterine Neoplasms |
|
resveratrol |
11.66 | 17044934 |
MESH:D014594 |
Uterine Neoplasms |
|
sulindac sulfide |
11.66 | 18645019 |
MESH:D014604 |
Uveal Neoplasms |
|
decitabine |
10.00 | 17785578 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
10.00 | 16752155 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
8.94 | 1336536 |
MESH:D014605 |
Uveitis |
|
Dexamethasone |
8.94 | 1336536 |
MESH:D014625 |
Vaginal Neoplasms |
|
Cisplatin |
19.74 | 15577323 |
MESH:D014625 |
Vaginal Neoplasms |
|
Dacarbazine |
19.74 | 15577323 |
MESH:D014625 |
Vaginal Neoplasms |
|
Diethylstilbestrol |
19.74 | 16513791 16002989 |
MESH:D014625 |
Vaginal Neoplasms |
|
Zidovudine |
19.74 | 12579204 |
MESH:D014652 |
Vascular Diseases |
|
Arsenic |
15.44 | 17056641 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
15.44 | 17056641 |
MESH:D014652 |
Vascular Diseases |
|
Thalidomide |
15.44 | 15741222 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
3.74 | 12125929 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
7.63 | 17678736 16364871 17638931 17334414 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
resveratrol |
7.63 | 17488730 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
3.26 | 16761959 |
MESH:D014839 |
Vomiting |
|
Cisplatin |
3.87 | 11897121 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
3.39 | 15886252 |
MESH:D015430 |
Weight Gain |
|
Dietary Fats |
3.01 | 16723640 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
3.24 | 16287080 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
3.59 | 17120751 |